Monoamine-sensitive adenylate cyclase in the nervous system of the locust schistocerca gregaria by Kilpatrick, Andrew Thomas
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
MONOAMINE-SENSITIVE ADENYLATE CYCLASE
IN THE NERVOUS SYSTEM
OF THE LOCUST SCHISTOCERCA GREGARIA
by
ANDREW THOMAS KILPATRICK
A Thesis submitted 
to the University of Glasgow 
for the degree of
DOCTOR OF PHILOSOPHY
Department of Biochemistry June 19 81
ProQuest Number: 10646032
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uesL
ProQuest 10646032
Published by ProQuest LLO (2017). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
For Sheila and Melissa-Jayne
ACKNOWLEDGEMENTS
Dr. P.F.T. Vaughan for his continuous guidance and constant 
interest in my research. His supervision and constructive 
criticism were always appreciated.
Professor R.M.S. Smellie and Professor A.R. Williamson for pro­
viding facilities for the duration of my research.
Shell (UK) and the Science Research Council for providing the 
post-graduate CASE award.
Dr. J.F. Donnellan and Mr. B. Clarke for making my stay at 
Sittingbourne Research Centre a memorable one.
Mr. Andrew Wilson of the Biochemistry Department for his tech­
nical assistance.
My Wife and Parents for their continued financial and moral 
encouragement whilst 1 was at the University of Glasgow.
ABBREVIATIONS
App (NH) p 
ATP
Cyclic AMP (cAMP)
EDTA
EGTA
GDP
Gpp(NH)p 
Gpp(CH^ip 
GTP(y )S 
GTP-ase 
NADH 
TRIS
Adenyly1-imidodiphosphate
Adenosine-5'-triphosphate
Adenosine-35'-cyclic phosphate
Ethylenediaminetetra acetic acid
1,2-Di (2-arainoethoxy)-ethane-N N N'N'- 
tetra acetic acid
Guanosine-5'-diphosphate
Guanyly1-imido diphos ph ate
Guanylyl-[gy-methylene]-diphosphate
Guanosine-5'-O-(3-thiotriphosphate)
Guanosine triphosphatase
Reduced nicotinamide-adenine dinucleotide 
2-Amino-2-hydroxymethylpropane-1,3-diol
CONTENTS
Page
SUMMARY 1
INTRODUCTION 4
Distribution of Noradrenaline, Dopamine, Octopamine 5
and Serotonin
1. Noradrenaline ^
2. Dopamine 8
3. Octopamine 9
4. Serotonin 10
Role of Monoamines in Nervous System 10
1. Receptor Classification 11
2. Identification of Monoamine Receptors 14
2.1 Dopamine 14
2.2 Octopamine 15
2.3 Serotonin 16
Cyclic AMP Role in Synaptic Transmission 17
1. Model for the Involvement of Cyclic AMP in 20
Neurotransmission
Evidence for the Model 20
1. Sub-cellular Localisation 20
2. Monoamine-Sensitive Adenylate Cyclase 22
2.1 Vertebrate 22
2.2 Invertebrate 25
3. Cyclic AMP-Dependent Phosphodiesterase 26
4. Receptors for Cyclic AMP 27
5. Phosphorylation of Membrane Proteins 2 8
Tyrosine Hydroxylase Activation by Cyclic AMP 29
Control of Adenylate Cyclase 30
CONTENTS CONTINUED
Page
1. Guanyl Nucleotides 30
2. Calcium and Calmodulin 34
Advantages and Structure of Insect CNS 35
1. Advantages 35
2. Structure 37
Objectives of this Thesis 37
MATERIALS AND METHODS 39
Materials 39
Methods 41
1. Tissue Preparation 41
1.1 Preparation of Crude Membrane Fractions 41
(pfl and pf2)
1.2 Formation of Stable Complex 4 3
1.3 Sub-cellular Fractionation 43
2. Measurement of Adenosine-35’Cyclic Phosphate 45
3. Enzyme Assays 4 8
3.1 Adenylate Cyclase 4 8
3.2 Cyclic AMP Phosphodiesterase 49
3.3 Glutamate Dehydrogenase 50
3.4 Glycerol-3-phosphate Dehydrogenase 51
3.5 Acetylcholinesterase 52
4. Protein 53
5. Mounting and Staining Cerebral Ganglia 5 3
5.1 Embedding and Sectioning 53
5.2 Staining 55
6. Preparation of AG-1-X8 Columns 55
7. Statistics 56
CONTENTS CONTINUED
Studies on Washed Pellet Fraction (pf^ )
Page
8. % Additivity 56
9. % Inhibition 57
RESULTS 5 8
Studies on Crude Homogenate 5 8
1. Effect of Monoamines 58
61
1. Effect of GTP and Octopamine Concentrations 54 
on Adenylate Cyclase
2. Effect of Monoamines on Adenylate Cyclase 57
3. Magnesium/ATP Ratio 57
4. Effect of Time and Temperature on Adenylate 70
Cyclase
5. Sub-cellular Localisation of Octopamine- 75
Stimulated Adenylate Cyclase
6. Effect of Octopamine and Theophylline on 83
Phosphodiesterase
Evidence for Separate Receptors for Octopamine, 83
Dopamine and Serotonin
1. Additive Effects of Octopamine, Dopamine and 86
Serotonin
2. Use of Antagonists 86
Role of Guanine Nucleotides in the Activation of 9 5
Adenylate Cyclase
1. Preliminary Studies 95
2. Time Course 9 8
3. Ka for Gpp(NH)p Activation 103
4. Formation of Stable Complex 10 3
5. Effect of GDP on Adenylate Cyclase 110
CONTENTS CONTINUED
Page
DISCUSSION 115
Monoamine-Stimulated Adenylate Cyclase 115
1. Characterisation of Octopamine Receptors 117
2. Evidence for Separate Receptors 118
2.1 Additive Experiments 118
2.2 Use of Agonists and Antagonists 120
Thé Role of Neurotransmitter/Hormone and Guanyl 122
Nucleotides in the Regulation of Adenylate Cyclase
1. Activation by Guanine Nucleotides 123
2. Formation of Stable Complex 125
3. Role of GDP in Adenylate Cyclase Regulation 126
3.1 Catecholamine-Stimulated GTP-ase 126
3.2 Cholera Toxin 12 8
3.3 Effect of GDP on Adenylate Cyclase 129
Hormone-Guanyl Nucleotide Regulation of Adenylate 131
Cyclase
1. Rat Liver Adenylate Cyclase 131
2. Neuroblastoma Adenylate Cyclase 133
Future Studies 137
REFERENCES 143
SUMMARY
The observation that dopamine, octopamine and serotonin repre­
sent the major monoamines present in insect nervous tissue has 
led to speculation about their role. For the monoamines to act 
as neurotransmitters, receptors should exist. Moreover, if 
chemical neurotransmission involves cyclic AMP as a "second 
messenger", then monoamine receptors linked to adenylate cyclase 
should also be present. The aim of this work was to determine 
whether locust cerebral ganglia possessed an adenylate cyclase 
that was affected by these monoamines present in Schistocerca 
qreqaria nervous tissue and, if so, to see if the response was 
mediated by separate receptors. In addition, a comparison of 
the properties of the locust adenylate cyclase with those from 
other organisms was carried out.
Cerebral ganglia of S. qreqaria contain an adenylate cyclase
-4stimulated maximally, in the presence of 10 M GTP, by octopa­
mine (10 ^M), dopamine (10 M^) and serotonin (10 ^M). The pre­
ferential inhibition of the octopamine-, dopamine- and serotonin- 
stimulated adenylate cyclase by phentolamine (8 )iM) , chlorpro- 
mazine (10 pM) and cyproheptadine (10 pM) respectively, toge­
ther with the ability of any combination of saturating amounts 
of the monoamines to stimulate in an additive manner suggests 
that activation occurs via separate receptors.
The replacement of GTP (10 M^) by Gpp(MH)p (10 M^) leads to a 
greater efficiency of activation of locust adenylate cyclase in 
a pellet fraction. Furthermore, this activation appeared to be 
independent of octopamine, dopamine or serotonin. However,
additional washing of the membrane preparation revealed an octo- 
pamine-sensitive component which could be inhibited by phento­
lamine (80 |iM) . The failure of phentolamine to reduce the 
Gpp(NH)p activation suggests that endogenous octopamine is not 
primarily responsible for the activity.
Gpp(NH)p (10 M^) forms an active stable enzyme complex with S . 
qreqaria adenylate cyclase similar to that observed with 
cyclases from other organisms. Complete reversal of this lo­
cust enzyme complex required the simultaneous addition of octo­
pamine (10 "^M) and GTP (10 M^) .
Time course experiments showed that a lag occurred in the acti­
vation of rat liver adenylate cyclase in the presence of 
Gpp(NH)p. Furthermore, this lag was abolished by glucagon.
Thus, it was suggested that a slow isomérisation of adenylate 
cyclase from an inactive to active form of the enzyme was res­
ponsible for the lag. The failure of the locust enzyme in time 
course experiments to display a lag in the presence of Gpp(NH)p 
(10 M^) suggests that if a transition state exists, its inter­
conversion must be rapid.
— 4Pre-incubation of locust adenylate cyclase with GTP (10 M) 
followed by the addition of Gpp(NH)p (10 "^M) led to a lag in 
activation in time course experiments. This lag was abolished 
by octopamine. However, although the evidence is not conclusive 
this lag most likely represents the time necessary for Gpp(NH)p 
to remove the tightly bound nucleotide from its binding site. 
Furthermore, octopamine would appear to facilitiate its ex­
change .
The inhibition of Gpp(NH)p activation by GDP (10 and 10 M^) 
together with the reduced stimulation observed with octopamine 
(10 and GDP (10 in the presence of App(NH)p suggests
that GDP may produce an inactive form of the enzyme.
INTRODUCTION
Many of the biochemical and physiological responses of target 
cells to circulating hormones depend on the action of adenosine­
s '  :5'-cyclic phosphate (cyclic AMP). For example, cyclic AMP, 
regarded as a "second messenger" which translates the extra­
cellular message of the hormone into an intra-cellular response, 
is involved in glycogenolysis, lipolysis and the release of 
thyroid stimulating hormone (Robison et al, 19 71).
The observation that the CNS has the highest activity of adenylate 
cyclase, the enzyme which catalyses the conversion of ATP to 
cyclic AMP of any mammalian tissue studied (Sutherland et al,
1962) and that the activity varied considerably in different 
brain regions (Weiss and Costa, 1968) prompted research into its 
involvement in brain function (Greengard et al, 19 72). In non- 
neural tissue, it was suggested that cyclic AMP-mediated responses 
occurred through binding of the hormone to specific receptors on 
the target cell surface (Robison et al, 1967). If cyclic AMP 
acts as a "second messenger" in the nervous system, then a 
"primary messenger" (neurotransmitter) and receptor should exist. 
Evidence has accumulated that some putative neurotransmitters 
(noradrenaline, dopamine, serotonin, histamine, glutamate, 
asparate, substance P) can alter cyclic AMP levels, both in 
intact cells and cell-free systems (Daly, 1976).
Before describing the evidence for a possible role of cyclic 
AMP in brain function, the distribution of the monoamines, 
noradrenaline, dopamine, serotonin and octopamine in vertebrate 
and invertebrate nervous systems will be discussed.
Distribution of Noradrenaline, Dopamine, Octopamine and Sero- 
tonin
1. Noradrenaline
Noradrenaline, first identified as the neurotransmitter 
substance of adrenergic nerves in the peripheral nervous 
system (Von Euler, 1946), was later identified as a normal 
constituent of mammalian brain (Holtz, 1950) and a specia­
lised function for noradrenaline was suggested by its non- 
uniform distribution (Vogt, 1954). Thus, the highest con­
centration of noradrenaline was found in the hypothalamus 
(Table 1). In rat brain, noradrenaline-containing neurons 
originate from cell bodies situated in the pons and medulla 
oblongata. These cell bodies give rise to the ascending 
pathways to the cortical area, limbic system and hypo­
thalamus and the descending pathways to the spinal cord 
(Cooper et al, 1978),
In many invertebrate nervous tissues, noradrenaline, al­
though present, exists at lower concentrations than that 
observed for dopamine and octopamine (Table 2). The ab­
sence of evidence for the presence of specific noradren­
ergic neurons in insects has suggested that the nor- . 
adrenaline detected in insect nervous tissue is either due 
to the presence of a small class of as yet unidentified 
noradrenergic neurons or is the result of a metabolic 
artefact (Evans, 19 80). Such an artefact could arise if 
released dopamine was taken up by octopaminergic neurons 
and converted to noradrenaline by tyramine-B“hydroxylase.
TABLE 1
Monoamine Distribution in Vertebrate Central Nervous System
Species Brain Region
NA
tissue
(j^ g/g)
DA
tissue
(^g/g)
OCT
tissue
(ng/g)
SER
tissue
(pg/g)
OCT/
NA
Ratio
Dog Whole Brain 0.16 0.19 — — —
Medulla 0.37 0.13 - 0,55 —
Cerebellum - - - 0.07 -
Hypothalamus 1.00 - - 1.75 -
Cerebral Cortex 0.05 - - 0.17 -
Caudate Nucleus 0.10 5.90 - - -
Cat Whole Brain 0.22 0.28 wmm — —
Medulla - - - 0.55 -
Cerebellum - - - 0.27 -
Hypothalamus 1.40 - - 1.78 -
Cerebral Cortex - - - 0.24 -
Caudate Nucleus 0 . 10 9.90 - - -
Rat Whole Brain 0.49 0.60 — — —
Medulla 0. 72 - 5.38 - 0.007
Cerebellum 0.17 - 3.38 - 0.02
Hypothalamus 1.29 0.14 13.52 - 0.01
Cerebral Cortex 0.28 0.01 4.04 - 0.023
’Caudate Nucleus 0.27 6.39 - - -
Data for noradrenaline (NA) 
and dopamine (DA)
Data for octopamine (OCT)
Data for serotonin (SER)
Iversen and Iversen, 196 7
Buck et al, 1977 
Udenfriend et al, 1957
TABLE 2
Monoamine Distribution in Invertebrate Brain Tissue
Species
NA
tissue
(p-g/g)
DA
tissue
(^g/g)
OCT
tissue
(pg/g)
SER
tissue
(pg/g)
OCT/NA
Ratio
Periplaneta americana O.37I 2.35
Schistocerca qreqaria 0.113 0.87
Locusta miqratoria 0.245 1.31
Helix aspersa 0.075 5.16
Octopus vulqaris 4.40* 11.90
4.52%
2.433
0.13? 
1.20 G
1.40**
2.345
5.10®
3.70*
11.5
22.0
1.8
0.3
Superscript numbers indicate references
1. Frontali and Haggendal, 19 69
2. Robertson and Steele, 19 73
3. Robertson, 19 7 6
4. Klemm and Axelsson, 19 73
5. Hiripi and S-Rozsa, 1973
6. Juorio and Killick, 1972
7. Robertson and Juorio, 1976
8. Juorio and Molinoff, 19 74
2. Dopamine
Dopamine, identified in sympathetic nerves and ganglia 
(Schuman, 19 56), was also demonstrated to be present in 
mammalian brain (Table 1). Dopamine distribution differed 
markedly from that of noradrenaline. Unlike noradrenaline, 
the highest level of dopamine was not in the hypothalamus, 
but in the caudate nucleus suggesting that dopamine existed 
independently of noradrenaline and that the dopamine pre­
sent was not merely as a precursor for noradrenaline. Two 
dopaminergic pathways in mammalian brain have been identi­
fied using fluorescence spectroscopy.
a) The nigro-striatal DA fibres which originate in the 
substantia nigra and ascend through the lateral and 
mid hypothalamus, fanning out to innervate the neo­
striatum ,
b) The mesolimbic DA fibres which originate principally 
from DA cell bodies surrounding the interpenduncular 
nucleus and ascend to innervate the limbic forebrain 
(Livett, 1973).
In invertebrates, dopamine is present in specific neurons of 
the molluscs Helix aspersa (Sedden et al, 196 8) , Planor- 
bis corneus (Marsden and Kerkut, 19 70) and Lymnaea stag- 
nalis (Cottrel et al, 1979) and has been identified in a 
wide variety of invertebrate species (Table 2). In insects, 
dopamine is a major phenylethylamine when compared with 
noradrenaline.
3. Octopamine
Octopamine, identified in sympathetic nerves of rats (Mo­
linoff and Axelrod, 1959, 1972), has been shown to have a 
non-uniform distribution in rat brain (Buck et al, 19 77). 
Octopamine has only been found in areas of the brain that 
contain noradrenaline. This, together with the failure to 
detect specific octopaminergic cells, has suggested that 
the small amounts of octopamine found in mammalian brain 
are a result of a metabolic mistake, since the enzymes, aro­
matic amino acid decarboxylase and g-hydroxylase, which are 
thought to be involved in the synthesis of octopamine, are 
present in noradrenergic neurons. The highest level of 
octopamine (13,5 ng/g tissue) present in the hypothalamus 
is only 1% of the level of noradrenaline (Table 1).
Octopamine is widely distributed in many invertebrate 
species (Table 2) and it is suggested that the medial 
group of dorsal unpaired cells of the locust (Evans and 
O’Shea, 1977, 19 78) and the cockroach (Dymond and Evans,
19 79) are octopaminergic, A phylogenetic relationship 
between the ratio of the levels of octopamine and noradre­
naline in nervous tissue has been suggested (Robertson and 
Juorio, 1976). In protostomes (insects, crustaceans, 
annelids and gastropods), octopamine predominates over 
noradrenaline whereas in deuterostomes (echinoderms and 
mammals), the situation is reversed (Tables 1 and 2).
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4. Serotonin
Serotonin, first identified as a naturally occurring vaso­
dilator in serum (Rapport, 1949), was later identified in 
the nervous system of the dog (Amin et al, 19 54) . In 
mammalian brain, serotonin was not randomly distributed 
but localised in definite areas (Udenfriend et al, 1957) . 
Thus, the hypothalamus contained the highest level of 
serotonin (Table 1). Fluorescence microscopy has identi­
fied that serotonin-containing neurons are localised in 
the raphe nuclei which are a series of nuclei in the lower 
midbrain and upper pons (Aghajanian, 19 72).
Serotonin is present in a wide variety of invertebrates 
(Table 2) and serotonin-containing neurons have been iden­
tified in the nervous system of the annelid Lumbricus 
terrestris (Rude, 1966) Myhrberg, 1967). Although present 
in many insect species, it has not been detected in the 
caddis fly (Bjorklund et al, 19 70) Klemm and Bjorklund,
1971) .
Role of Monoamines in Nervous System
The evidence presented suggests that dopamine, octopamine and 
serotonin represent the major monoamines present in insect 
nervous tissue. This has led to speculation about their role. 
For the monoamines to act as neurotransmitters, receptors should 
exist. Moreover, if neurotransmission involves cyclic AMP as a 
"second messenger", then monoamine receptors linked to adenylate
11
cyclase should also be present. Before describing the possible 
involvement of cyclic AMP in mediating neurotransmission and the 
evidence for monoamine-sensitive adenylate cyclases, the classi­
fication and identification of monoamine receptors in vertebrate 
and invertebrate nervous tissues will be discussed.
1. Receptor Classification
The characterisation and classification of receptors have 
depended historically upon the relative effects of various 
compounds on biological activity e.g. noradrenaline in the 
sympathetic nervous system stimulated the contraction of 
vascular smooth muscle and relaxation of smooth muscle in 
the intestine. Both types of receptor respond to the 
catecholamines noradrenaline, adrenaline and isoproterenol, 
but the effectiveness of these agonists on the two recep­
tors is quite different. For example, with a-adrenergic 
receptors, adrenaline > noradrenaline >isoproterenol and 
for g-receptors, isoproterenol > adrenaline > noradrena­
line (Alquist, 1948). Antagonists which are relatively 
selective for either a- or g-receptors are well known. 
Phentolamine, whose structure is given in Figure 1, is 
an a-antagonist whereas propranolol is a ^“antagonist 
(Table 3). Classical antagonists of a- or g-adrenergic 
receptors are ineffective as antagonists of dopamine re­
ceptors (Kebabian et al, 19 72) but anti-psychotic drugs 
are potent antagonists (Clement-Cormier et al, 197 2) 
Karobath and Leich, 19 74) . Cyproheptadine, lysergic acid, 
diethylamine are suggested serotonin antagonists (Nathan- 
son and Greengard, 1974),
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FIGURE 1
Structures of the Antagonists ;
Phentolamine, Propranolol, Cyproheptadine and Chlorpromazine
CH
NCH
.N-
OH
'N-
I
H
OCHgCHOHCHgNHCHfCH])^
Phentolamine
{a-antagonist)
Propranolol 
(3“antagonist)
CH.
Cyproheptadine
(serotoninergic 
antagonist)
S
Cl■N
I
Chlorpromazine 
(dopaminergic antagonist)
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TABLE 3
Monoamine Antagonists
Monoamine Antagonists
Receptor
Type Antagonist
a-Receptors
3-Receptors
Dopamine
Receptors
Serotonin
Receptors
Phentolamine, tolazoline, phenoxybenzone 
Propranolol, pronethalol
Phenothiazines (e.g. fluphenazine, chlorpromazine) 
Thioxanthenes (e.g. clothiapine, clozapine) 
Butyrophenones (e.g. haloperidol, spiroperidol) 
Cyproheptadine, lysergic acid diethylamide
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2. Identification of Monoamine Receptors
2.1 Dopamine
Pharmacological evidence indicates the existence of 
different classes of dopamine receptors, for example, 
the neuroleptic drug haloperidol competes with dopa­
mine for dopamine binding sites (Seeman et al, 1975) 
Creese et al, 1975).but is relatively weak as an in­
hibitor of dopamine-sensitive adenylate cyclase. In 
rat striatum, the neurotoxin kainic acid, almost 
totally depleted dopamine-sensitive adenylate cyclase 
activity but only elicited a 40-50% decline in [^H]- 
haloperidol binding (Schwartz et al, 197 8), Based on 
studies such as these, Kebabian and Caine, 19 79 
classified the dopamine receptors as D-1 and D-2. D-1 
receptors have effective agonists in the fxmolar range, 
are linked to adenylate cyclase and are not 
affected by the anti-psychotic drug sulpiride. D-2 
receptors, however, are stimulated by agonists in the 
nmolar range, are not linked to adenylate cyclase and 
are antagonised by sulpiride.
In invertebrate nervous tissue, studies on the mol­
lusc Helix aspera have identified neurons that are 
inhibited (Woodruff and Walker, 1969) Woodruff, 1971) 
and excited (Stryker-Boudier et al, 19 74) by dopamine.
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2.2 Octopamine
lontophoretic application of octopamine to unidenti­
fied neurons of Aplysia californien resulted in a 
slow hyperpolarisation suggesting the existence of 
octopamine receptors. Dopamine had no effect while 
noradrenaline gave a small response (Carpenter and 
Gaubatz, 1974). However, the response to noradrena­
line was considered negligible as A. californica 
nervous tissue does not contain noradrenaline (Saav- 
adra et al, 19 7 4). From studies on cell E26 in the 
sub-oesophageal ganglia of H. aspersa, octopamine was 
found to be excitatory and dopamine and noradrenaline 
inhibitory (Batta et al, 1979). Phentolamine (2 x 
10 M^) blocked the excitatory action of octopamine 
without affecting the dopamine and noradrenaline res­
ponse ,
In the locust, the extensor-tibiae muscle of the hind 
leg is a large and powerful muscle used in walking, 
kicking and jumping. It is innervated by the fast and 
slow extensor motoneurons and an inhibitory moto­
neuron (Hoyle and Burrows, 1973). The muscle also 
receives a fourth axon from the dorsal unpaired me­
dian extensor tibiae (DUMETi) neuron (Hoyle et al,
19 74) which originates from the region of the DUM 
cells in the meta thoracic ganglia. Cells from the 
DUM region, when incubated with labelled tyrosine, 
synthesised tyramine and octopamine but there was no 
evidence for the synthesis of either noradrenaline or
16
dopamine (Hoyle and Barker, 1975), The identifi­
cation of octopamine (0.1 pmole/cell soma) 
in DUMETi cells (Evans and O'Shea, 1977) and the ob­
servation that stimulating the DUMETi neuron potenti­
ated the extensor muscle tension generated by the 
slow extensor motoneuron (Evans and O ' Shea, 19 77) 
and that this potentiation was mimicked by exoge­
nously applied octopamine (10 M^) and blocked by 
phentolamine, suggested that the DUMETi neuron was 
octopaminergic (Evans, 1980).
2.3 Serotonin
In the rat, serotonin appears to exert an inhibiting 
effect both on serotonin-containing neurons of the 
raphe nuclei as well as neurons receiving seroton­
ergic connections from the raphe nuclei (Haigler and 
Aghajanian, 19 74).
In invertebrates, certain gastropod neurons may be 
depolarised and excited by serotonin (Gershenfeld and 
Stefani, 1966). In H. aspersa, serotonin has two in­
hibitory actions (Gershenfeld, 1971) as it stimulates 
either an influx of chloride ions or an efflux of 
potassium.
Before cyclic AMP can be considered as a "second 
messenger", a biochemical and physiological response 
to cyclic AMP must be demonstrated. Much of our
17
understanding of the possible role of cyclic AMP in 
brain function is derived from studies on the mamma­
lian superior cervical ganglion.
Cyclic AMP - Role in Synaptic Transmission
Superior cervical ganglia receive three types of innervation. 
Acetylcholine (ACh) released from preganglionic terminals acti­
vates nicotinic receptors in the postganglionic neuron, leading 
to the generation of the fast-excitatory post-synaptic poten­
tial (f-epsp). In addition, stimulation of muscarinic cholin­
ergic receptors leads to the generation of a slow-excitatory 
post-synaptic potential (s-epsp), a process which may involve 
cyclic GMP (Kebabian et al, 197 5) . Acetylcholine also acti­
vates muscarinic receptors within the interneuron, leading to 
the release of dopamine from small intensely fluorescent (SIF) 
cells within the interneuron (Libet and Owman, 19 74). The re­
leased dopamine activates a dopamine receptor causing the gene­
ration of a slow-inhibitory post-synaptic potential (s-ipsp), 
a process which seems to involve cyclic AMP (Greengard et al,
19 72). A diagram of the principal synaptic connections that 
occur within the superior cervical ganglia is shown in Figure 2
Dopamine applied exogenously caused a rise in cyclic AMP levels 
in the sympathetic ganglia of the cow (Kebabian and Greengard, 
1971) , rabbit (Kalix et al, 1974) and cat (Black et al, 1978) .
Electrical stimulation of preganglionic fibres elicited a two­
fold increase in cyclic AMP levels in rabbit superior cervical
FIGURE 2
Schematic Diagram of the Principal Synaptic 
Connections in the Mammalian Superior Cervical 
Ganglion and the Postulated Roles of Cyclic AMP 
and Cyclic GMP in the Generation of 
the Post-ganglionic Synaptic Potentials
Nicotinic
Cholinergic
ACh
s-epsp
_Chollnergl^=-=^
Post-ganglionic
Neuron
Pre-ganglionic
Nerve Fibres
Dopaminergic
cAMP
s-ipspDopamine
Interneuron
ACh
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ganglia (Greengard et al, 1972) a four-fold increase in cat 
(Chatzkel et al, 19 74) and an eight-fold increase in the bull­
frog (Weight et al, 1974). Postganglionic stimulation of rabbit 
superior cervical ganglia had no effect (Greengard et al, 1972). 
The rise in cyclic AMP in rabbit was blocked by atropine, a 
muscarinic cholinergic antagonist or by a-adrenergic antago­
nists (Kalix et al, 1974) leading to a reduction in the s-ipsp 
response. The rise in cyclic AMP was mimicked by the muscari­
nic agonist bethanechol (Kalix et al, 1974). If monobutyryl 
cyclic AMP was added to rabbit superior cervical ganglia, a 
s-ipsp response was obtained which was similar to that observed 
with preganglionic stimulation (McAfee and Greengard, 1972). 
These studies suggested that cyclic AMP mediated dopaminergic 
transmission in the rabbit superior cervical ganglion and that 
cyclic AMP through the generation of the s-ipsp regulated the 
membrane potential of the postganglionic neuron (Greengard, 
1976).
However, a number of objections have been raised to Greengard's 
interpretation that the role of cyclic AMP is to mediate the 
s-ipsp. In bullfrog ganglia, although electrical stimulation 
is known to elevate cyclic GMP and cyclic AMP (Weight et al,
19 74), cyclic nucleotide administration did not mimic the mem­
brane potential associated with the generation of the respective 
s-epsp and s-ipsp potentials (Weight et al, 1978) suggesting 
that its generation was independent of cyclic nucleotides. In 
rabbit superior ganglia, the addition of dibutyryl cyclic AMP 
caused an increase in the s-epsp (Libet et al, 1975) but had no 
effect on the s-ipsp (Libet, 1979) .
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1, Model for the Involvement of Cyclic AMP in Neurotrans­
mission
The model proposed by Greengard et al, 19 72 for the pos­
sible mechanism by which cyclic AMP can mediate dopaminer­
gic transmission in the superior cervical ganglion has been 
extended to chemical neurotransmission in the central 
nervous system (Greengard, 1976) (Figure 3).
It is proposed that;
a) the post-synaptic action of a number of neurotrans­
mitters may be mediated through the action of cyclic 
AMP or cyclic GMP
b) the immediate target of cyclic AMP and cyclic GMP is 
the protein kinases whose action results in the phos­
phorylation of specific membrane proteins. Further­
more, the alteration of the degree of phosphorylation 
of these proteins produce the physiological effect of 
the neurotransmitters.
Evidence for the Model
1. Sub-cellular Localisation
Differential centrifugation has permitted the isolation of 
distinct populations of sub-cellular organelles from mamma-
i
lian brain (Whittaker, 1968*, De Roberts et al, 1965) .
A
21
FIGURE 3
Proposed Role of Cyclic AMP in Generating Postsynaptic Potential
Presynaptlc Neuron
Neurotransmitter
Postsynaptic
Neuron
Receptor
Adenylate
Cyclase
Phosphatase 
Protein Protein-PO,
Kinase
Electrogenic
Pump
Membrane
Potential
/ Cyclic AMP
The released neurotransmitter activates an adenylate cyclase. 
The cyclic AMP produced activates cyclic AMP-dependent protein 
kinase which catalyses the phosphorylation of a substrate pro­
tein, a protein which controls the permeability of the post­
synaptic membrane. Phosphorylation of this protein thus leads 
to a change in membrane potential. Termination occurs through 
hydrolysis of cyclic AMP by phosphodiesterase and dephosphory­
lation of the substrate protein by a phosphatase.
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Nuclei, capillaries, myelin, mitochondria, nerve endings 
(synaptosomes) and microsomes have been identified.
The five proteins postulated in the model for the post­
synaptic neurons^ adenylate cyclase (De Robertis et al, 1967) , 
protein kinase (Maeno et al, 1971) , phosphodiesterase 
(Florendo et al, 1971) , protein kinase substrate (Johnson 
et al, 19 71) and phosphoprotein phosphatase (Maeno and 
Greengard, 19 72) are all present in high concentrations in 
those sub-cellular fractions of rat brain tissue that are 
richest in synaptic membranes.
2. Monoamine-Sensitive Adenylate Cyclase
2.1 Vertebrate
Considerable evidence exists for the presence of nor­
adrenaline-, dopamine- and, to a lesser extent, sero­
tonin-stimulated adenylate cyclases in vertebrate 
nervous tissues. In contrast, little is known about 
octopamine.
Electrophysiological studies showed that noradrenaline 
applied iontophoretically to the cerebellum results 
in a hyperpolarisation and a slowing of the discharge 
rates of the Purkinje cells (Hoffer et al, 1971)
Siggins et al, 19 71a). This effect was potentiated by 
the phosphodiesterase inhibitors, theophylline and 
papaverine (Siggins et al, 1971b) and mimicked by ion-
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tophoretically applied dibutyryl cyclic AMP and 
cyclic AMP (Hoffer et al, 1971). Fluphenazine and 
a-flupenthixol were potent antagonists of nor­
adrenaline inhibition of Purkinje neurons (Freedman 
and Hoffer, 1975) Skolnick et al, 1976) . Ionto­
phoresis of lithium antagonised noradrenergic inhi­
bition of rat Purkinje cells (Siggins et al, 1979). 
Lithium is a known antagonist of noradrenaline in­
duced increase in cyclic AMP (Forn and Valderasas, 
1971). Electrical stimulation of the locus coeruleus 
also caused a slowing of the firing rate of Purkinje 
cells (Siggins et al, 1971c) Hoffer et al, 1972) 
through noradrenaline projections which terminate on 
Purkinje cell dendrites. Using an immunofluorescence 
technique for the histochemical detection of cyclic 
AMP, it was shown that either topical application of 
noradrenaline to cerebellum or electrical stimulation 
of locus coeruleus elicited an increase in the fluo­
rescence of Purkinje cells (Siggins et al, 19 73) 
suggesting an increased formation of cyclic AMP.
Based on studies such as these. Bloom, 1975 suggested 
that noradrenaline released from noradrenergic termi­
nals originating from neurons in the locus coeruleus 
regulated spontaneous electrical activity in Purkinje 
cells by a mechanism involving a noradrenaline-sensi­
tive accumulation of cyclic AMP within the Purkinje 
cell.
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A noradrenaline-sensitive adenylate cyclase is pre­
sent in the cerebral cortex of sheep, steer (Klainer 
et al, 19 62) , rat (Van Inwegan et al, 19 75) and in 
rat corpus striatum (Harris, 19 7 8). In homogenates of 
rat limbic forebrain, although a two fold increase in 
adenylate cyclase activity was observed with nor­
adrenaline, the addition of octopamine had no effect 
(Horn and Philipson, 1976). In contrast to the ab­
sence of evidence for an adenylate cyclase stimulated 
by octopamine in vertebrate nervous tissue, consider­
able evidence exists for dopamine. A dopamine-sensi­
tive adenylate cyclase is present in the mammalian 
caudate nucleus (Kebabian et al, 1972) Roufogalis et 
al, 19 79) , cortex, (Von Hungen and Roberts, 1973) , 
olfactory tubercle (Horn et al, 1974) Krieger, 1980) 
and nucleus accumbens (Horn et al, 19 74) Watling et 
al, 1979). The enrichment of a dopamine-sensitive 
adenylate cyclase in a crude synaptosome preparation 
(P2) from rat striatum (Clement-Cormier and George,
19 78) is consistent with its localisation in synaptic 
membranes.
A serotonin-sensitive adenylate cyclase was present 
in homogenates of several brain regions of newborn 
rat and guinea pig which declined during maturation 
(Enjalbert et al, 1977) and in slices of rat brain 
(Kakiuchi and Rail, 19 6 8). Others have reported no 
effect of serotonin on adenylate cyclase in rat brain
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homogenates (Bnrkard and Grey, 1968) Duffy and Powel,
19 75) or in synaptosomes from rat cerebral cortex 
(Izumi et al, 1975).
2.2 Invertebrate
The discovery of adenylate cyclase that is stimulated 
by octopamine and dopamine in the thoracic ganglia 
(Nathanson and Greengard, 19 73) and cerebral ganglia 
(Harmar and Horn, 1977) of the cockroach P. americana 
and the cerebral ganglia of M. configurate (Bodnaryk,
1979), L. miqratoria (Hiripi and S-Rozsa, 1980) and 
S. greqaria (Kilpatrick et al, 19 80) has provided 
additional support for a neurotransmitter function 
for octopamine and dopamine in invertebrates. In the 
cockroach, the effects of octopamine and dopamine upon 
adenylate cyclase activity were additive indicating 
the presence of separate receptors for these compounds 
(Nathanson and Greengard, 1973) Harmar and Horn, 1977). 
Although noradrenaline stimulated adenylate cyclase, 
the addition of noradrenaline to adenylate cyclase in 
the presence of octopamine and dopamine did not result 
in an increase in activity suggesting that noradrena­
line was having its effect by binding to either octo­
pamine or dopamine receptors. An octopamine-sensitive 
adenylate cyclase is present in the cerebral ganglia 
of the horseshoe crab Limulus polyphemus (Atkinson' 
et al, 1977).
A serotonin-sensitive adenylate cyclase found in the 
thoracic ganglia of P. americana was shown to be dis-
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tinct from the dopamine- and octopamine-sensitive 
adenylate cyclase (Nathanson and Greengard, 19 73).
The activation by serotonin was selectively inhibited 
by lysergic acid diethylamide, 2-bromolysergic acid 
diethylamide and, to a lesser extent, cyproheptadine, 
antagonists which are known to block serotonin recep­
tors (Nathanson and Greengard, 19 74), A serotonin- 
sensitive adenylate cyclase is present in cerebral 
ganglia of the locust S. gregaria (Kilpatrick et al,
1980) .
3. Cyclic AMP-Dependent Phosphodiesterase
Phosphodiesterase hydrolyses cyclic AMP to 5'adenosine 
monophosphate and is thought to represent the only means 
of inactivating cyclic AMP. Phosphodiesterase activity, 
which was initially detected in extracts of heart, brain 
and liver (Sutherland and Rail, 19 58) with brain having 
the highest activity, was subsequently shown to be widely 
distributed throughout the body (Butcher and Sutherland,
19 6 2). Most mammalian tissues contain three different 
phosphodiesterase isoenzymes which may be controlled 
separately. One phosphodiesterase has a high affinity for 
cyclic AMP (Thompson and Appleman, 19 71) whereas another 
has a higher affinity for cyclic GMP than cyclic AMP and may 
be regulated by calcium and a calcium-dependent regulatory 
protein (Calmodulin) (Kakiuchi and Yamazaki, 19 70). The 
third phosphodiesterase has a low affinity for cyclic AMP 
and is suggested to be regulated by cyclic GMP (Beavo et al, 
(1971) .
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In liver cells, glucagon stimulated the high affinity form 
of phosphodiesterase while the low affinity form was un­
altered (Allan and Sneyd, 1975). Calcium and calmodulin 
have more prominent effects on the lower affinity soluble 
cyclic AMP phosphodiesterase, when compared with the higher 
affinity membrane-bound phosphodiesterase (Thompson and 
Strada, 1978).
A variety of compounds including theophylline, caffeine and
3-isobutyl-1-methylxanthene have been reported to inhibit 
these phosphodiesterases (Levin and Weiss, 1976) Freedholm 
et al, 1976) Glass and Moore, 1979). However, a calcium- 
dependent phosphodiesterase from rat cerebellum was more 
strongly inhibited by trifluorperazine than the calcium- 
independent phosphodiesterase while theophylline was more 
effective as an inhibitor of the calcium independent form 
(Daly, 1977).
4. Receptors for Cyclic AMP
The receptors for cyclic AMP have been identified as the 
cyclic AMP-dependent protein kinases. Cyclic AMP acti­
vates protein kinase by binding to the regulatory sub-unit 
of the protein kinase which results in the dissociation of 
the holoenzyme into the regulatory and catalytic sub-unit 
[1] (Langan, 19 73) Rubin and Rosen, 1975).
R2C2 + 2 cyclic AMP f = = = = ^  R2 cyclic AMP + 2C [1]
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R is the regulatory sub-unit and C is the catalytic sub­
unit. ^2^2 inactive.
Two forms of soluble cyclic AMP-dependent protein kinase, 
designated Type I and Type II have been identified which 
differ in their distribution (Corbin et al, 1975) and bio­
chemical properties (Hoffman et al, 19 75). Type I and Type 
II are also membrane bound and are present in a wide 
variety of tissue (Uno et al, 1976). Mammalian brain is a 
rich source of both soluble and particulate enzymes (Hoff­
man et al, 19 77). In bovine cerebral cortex, 50% of the 
total kinase activity was localised in particulate frac­
tions whereas only 10% of the kinase activity observed in 
heart and skeletal muscle was membrane bound (Rubins et al, 
1979).
In brain, as in other tissue (Nimmo and Cohn, 19 77), mem­
brane and cytosol cyclic AMP-dependent protein kinases have 
identical catalytic sub-units but differ in their regula­
tory sub-units R^ and R^ (Walter et al, 19 78). Membrane 
bound Type II (but not Type I) cyclic AMP-dependent protein 
kinase is suggested to be the enzyme which phosphorylates 
membrane proteins in synaptic membranes (Walter et al,
1979) .
5. Phosphorylation of Membrane Proteins
Several proteins in synaptic membranes from mammalian 
brain can be shown to be phosphorylated in a cyclic AMP- 
dependent reaction (Uedo et al, 19 73). The proteins termed
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la and Ib and II (Tetsufumi and Greengard, 197 7) have 
different tissue distribution. Proteins la and Ib have 
been found exclusively in neural tissue whereas Protein II 
has a wide distribution (Ueda and Greengard, 1977).
The regulation of membrane potential suggested by Green­
gard, 19 76 is not the only proposed role for cyclic AMP in 
nervous tissue. For example, cyclic AMP has been impli­
cated in the control of the enzyme tyrosine hydroxylase.
5. Tyrosine Hydroxylase Activation by Cyclic AMP
Tyrosine hydroxylase catalyses the first and rate limiting
step in the biosynthesis of the catecholamines, dopamine
and noradrenaline. It requires oxygen, ferrous ions and
tetrahydropteridine co-factor for activity (Nagatsu et al,
19 6 4). The observation that brain tyrosine hydroxylase
activity was increased by cyclic AMP (Lloyd and Kaufman,
1975) Morgenroth.et al, 1975) raised the possibility that
tyrosine hydroxylase iriay be regulated by phosphorylation
and, if so, whether the enzyme itself was phosphorylated.
3 2Incubating tyrosine hydroxylase with [ P]-ATP, cyclic AMP
32and protein kinase and isolating the [ P]-labelled enzyme 
Joh et al, 19 78 demonstrated that the enzyme could be 
phosphorylated. The phosphorylation was cyclic AMP- 
dependent and increased the enzyme activity two fold with­
out any change in the apparent Km for either tyrosine or 
6-methyItetrahydropteridine. Other studies have suggested 
that under phosphorylating conditions, a reduction in the
30
Km for dimethyltetrahydropteridine (DMPH) was accompanied 
with the activation of tyrosine hydroxylase by cyclic AMP 
(Lloyd and Kaufman, 19 75).
Control of Adenylate Cyclase
Adenylate cyclase activity, although affected by neurotransmit­
ters or hormones, is thought to be controlled by GTP, calcium, 
macromolecular regulators and the availability of ATP within the 
cell (Daly, 1977).
The substrate for adenylate cyclase appears to be an ATP-metal 
complex (De Haen, 1974) Lin et al, 1975). Both magnesium-ATP 
and manganese-ATP, but not calcium-ATP, can act as substrates 
(Sutherland et al, 1962) Birnbaumer et al, 1969) Perkins, 1973) , 
and free ATP appears to act as an inhibitor (De Haen, 19 74) Lin 
et al, 1975).
1. Guanyl Nucleotides
The regulation of activity and hormone responsiveness of 
adenylate cyclase by GTP has been extensively studied in 
cell-free preparations and considerable evidence exists to 
show that adenylate cyclase requires the presence of both 
GTP and hormone or neurotransmitter for maximal activity 
(Rodbell et al, 1971', 1974) Levitzki, 1977). Guanyl nu­
cleotides have been reported to stimulate adenylate cyclases 
froiti a wide variety of tissue (Yamamara et al, 19 74) 
Roufogalis et al, 1976) Cassel and Selinger, 1977, 1978)
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Hoffman, 1919', Johnson and Makku, 1979). In rat brain, GTP 
stimulated basal adenylate cyclase activity (Roufogalis 
al, 1976) whereas others found it inhibitory (Clement- 
Cormier et al, 19 75, 19 7 8). GTP stimulated slightly ade­
nylate cyclase from rat cerebral cortex (Van Inwegan et al, 
1975).
If GTP was replaced by the non-hydrolysable analogue Gpp- 
(NH)p, adenylate cyclase from liver (Salomon et al, 19 75) 
and turkey erythrocyte (Sevilla et al, 1976) was converted 
to a "permanently" active state. This observation sugges­
ted that GTP is hydrolysed at the guanine regulatory site 
resulting in the deactivation of the enzyme (Levitzki,
1977) .
Various models have been proposed to explain the role of 
GTP in the activation of adenylate cyclase, but the two 
that will be discussed are:
a) the turkey erythrocyte (Levitzki, 19 78)
b) the liver enzyme (Salomon et al, 19 75)
a) Turkey Erythrocyte System
REGTP,
GTP
HRERE
GTP
HRE
K3 K4
GTP ►^^^'gTP ►HRE + GDP + Pi
Inactive Active Inactive
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R is the receptor, E the enzyme, is the rate of 
enzyme activation and the rate of enzyme deacti­
vation. Only the activated form (HRE'GTP) is capable 
of synthesising cyclic AMP. The hydrolysis of GTP to 
GDP and phosphate leads to the deactivation of the 
enzyme.
This model is based on the observation that i) acti­
vation of adenylate cyclase required the presence of 
both hormone (adrenaline) and Gpp(NH)p. Gpp(NH)p 
alone had little effect on adenylàte cyclase activity 
and ii) the formation of a stable complex with Gpp(NH)p 
and adrenaline was time dependent and could be pre­
vented by the addition of propranolol, a 3“anta­
gonist, Once the cyclase was fully activated, the 
addition of propranolol did not cause an inhibition.
If, however, propranolol was added during the for­
mation of the stable complex, the resulting activity 
depended on the time of addition of propranolol
(Sevilla et al, 1976) .
The necessity for hormone to be present for Gpp(NH)p 
activation in turkey eruthrocyte has been questioned 
by the observation that turkey erythrocyte membranes 
pre-treated with GMP and isoproterenol, a 3-anta­
gonist, and washed will display considerable adenylate
cyclase activity in the presence of Gpp(NH)p alone
(Lad et al, 1980).
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b) Liver Adenylate Cyclase
Guanyl Nucleotides Glucagon
E r— '■ -  ' -E'N —  E' ' N
Inactive Inactive Active
The basal state E, after binding of the guanyl nucleo­
tide alters to form E’N, an enzyme state that is still 
inactive. E''N is the active form of the enzyme and 
the conversion of E'N to E''N represents a rate- 
limiting step. Glucagon, the stimulatory ligand, 
acts by accelerating the rate of isomérisation to 
E ''N . This model is based on the observation that 
Gpp(NH)p alone can stimulate adenylate cyclase acti­
vity and that the activation displays a lag period 
which is abolished by the addition of glucagon (Salo­
mon et al, 19 75).
The receptor-dependent adenylate cyclase is composed 
of three basic units - the receptor, the GTP regula­
tory unit and the catalytic moiety which catalyses 
the conversion of ATP to cyclic AMP (Maguire et al,
19 77). It is suggested that the guanyl nucleotide 
alters the "coupling" between the hormone or neuro-; 
transmitter receptor and adenylate cyclase unit and 
the coupling factor resides in the GTP regulatory unit 
(Pfeuffer and Helmreich, 1975) Pfeuffer, 1977) .
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2. Calcium and Calmodulin
Brain tissue contains an adenylate cyclase that is acti­
vated by low (jiM) concentrations and inhibited by higher 
(mM) concentrations of calcium (Bradham et al, 19 70) Bros- 
trom et al, 1975) MacDonald, 1975). Calcium^inhibited 
forms of adenylate cyclase have been reported from a wide 
variety of tissue (Birnbaumer, 19 73) Jard and Bochaert, 
1975) .
A low molecular weight calcium binding protein (Calmodulin) 
conferred a calcium-dependent activation upon adenylate 
cyclase from porcine brain (Brostrom et al, 19 75) and rat 
cerebral cortex (Brostrom et al, 1977, 1978). Calmodulin 
is present in a wide variety of brain tissue (Cheung et al, 
1975) Gregg et al, 1976),
EGTA, a chelator which has a low affinity for magnesium 
compared with calcium (Holloway and Reilley, 1960) Sillin 
and Martel, 1964) has been considered a "specific calcium" 
chelator.
In rat brain slices (Schwabe and Daly, 1977) and rat cere­
bral cortex (Schwabe et al, 197 8), the rate of accumu­
lation of cyclic AMP elicited by noradrenaline was greatly 
reduced by EGTA. Following calcium depletion, the ability 
of glial tumour (C6) cells to accumulate cyclic AMP in res­
ponse to noradrenaline was reduced by 60-70% (Brostrom et
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al, 1979) . Micromolar free calcium was sufficient to re­
store the maximum noradrenaline response.
Advantages and Structure of Insect CNS
1. Advantages
The study of the central nervous system of mammals, espe­
cially in humans is made difficult by the large number of
neurons and interneural contacts involved. The human brain
12is suggested to contain about 10 neurons, many of which 
have as many as 10^ synaptic contacts distributed over the 
whole neuron (Eisenstein, 1972), The CNS of insects con­
tains relatively fewer neurons. The brain of the honey bee 
Apis melliféra contains approximately 8x10^ neurons and 
glial cells (Willhoft, 1967), whereas the fly Musca domes- 
tica contains approximately 3x10 neurons (Strausfeld, 1975) 
Insect neurons are concentrated in ganglia which are con­
nected in sequence by paired connectives. The number of 
ganglia varies in different species and developmental 
stages (Bullock and Horridge, 1965).
Decapitated insects are known to retain certain biological 
activities, for example, isolated thoracic ganglia of the 
cockroach are able to generate several types of leg move­
ments (Horridge, 1962), Many functions such as breathing 
and walking can be controlled by single ganglia isolated 
from the head ganglion (Hoyle, 19 70) giving the impression 
that they represent "mini" brains. There are two head 
ganglia, the "brain" (cerebral ganglion or supraoesophageal
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ganglion), which, innervates the mouth, neck muscles and sali­
vary gland (Klemm, 19 76) . The brain or cerebral ganglion 
consists of 4 or 5 or more fused ganglia (Bullock and Hor­
ridge, 1965), In contrast with vertebrate CNS, the cell 
body layer in insects is situated near the surface of the 
ganglia. Thus the somata are isolated from the neuropile, 
the region of the ganglia where synaptic cells are acces­
sible for electrophysiological and biochemical studies and 
can be identified from one preparation to the next. By 
recording the muscle tension generated at the same time as 
electrical activity in the penetrated neurons, the leg 
motor neurons in the locust metathoracic ganglia (Hoyle and 
Burrows, 1973) and the flight motor neurons in the locust 
mesothroacic ganglion (Bentley, 1970) were identified. 
Electrophysiological studies on the action of catecholamines 
on insect CNS have identified nerve cell bodies in the nerve 
cord of Periplaneta americana and Blabera craniifer that are 
excited by dopamine, noradrenaline and adrenaline (Piclon,
19 74). Another advantage of the insect is that the large 
cell bodies can provide sufficient material to measure le­
vels and synthesis of putative neurotransmitters. For 
example, the synthesis of octopamine by the dorsal un­
paired median neurons (Hoyle and Barker, 1975) and the 
identification of endogenous octopamine, present at 0.1 
pmole/cell soma in DUMETi cells (Evans and O'Shea, 1977).
The single identified neuron may also determine whether 
specific noradrenergic neurons exist and if found, provide 
evidence that noradrenaline does not act as a false neuro­
transmitter in insects.
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2, Structure
In the locust, the most anterior ganglion is the cerebral 
ganglion lying dorsal to the oesophagus in the head. From 
this ganglion, the circumoesophageal connectives pass one 
another, one on either side of the oesophagus to the first 
of a chain of ganglia lying ventrically in the haemocoel. 
The ganglia are joined to each other longitudinally by 
connectives made up of axons and supporting cells (Chap­
man , 19 69).
When S. gregaria cerebral ganglia are cut in sections, 3 
distinct regions are identified (Figures 4 and 5):
/■ a) the sheath or neural lamella which forms a fairly
permeable continuous membrane surrounding the ganglia
j b) a layer of cells composed of perineural and at least
three classes of neuroglia
c) the neuropile, a complex of afferent interneural and 
efferent fibres and their supporting glial elements
Objectives of this Thesis
The aim of this work was to determine whether locust cerebral 
ganglia possessed an adenylate cyclase that was affected by the 
major monoamines present in S. gregaria nervous tissue. If so, 
to see if the response was mediated by separate receptors and 
to compare the properties of the insect adenylate cyclase with 
those from other organisms.
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FIGURES 4 AND 5
Cross Sections of Cerebral Ganglion
B
X 4 8 magnification
xl45 magnification
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MATERIALS AND METHODS
Materials
All common laboratory reagents were of analytical grade. Fine 
chemicals were obtained as follows :
Adenosine-5'-triphosphate 
Adenosine-5'-diphosphate 
Adenosine-3'5'-cyclic phosphate 
Guanosine-5'-diphosphate 
DL-Octopamine hydrochloride 
5,5-Dithiobis (2-nitrobenzoic acid) 
Acetylthiocholine iodide 
Dihydroxyacetone phosphate 
Cobra venom (Ophiophagus hannah)
Sigma Chemical Company 
Kingston on Thames 
Surrey, KT2 7BH, UK
2-Oxoglutaric acid, disodium salt
Dopamine hydrochloride
1,2-Di (2-aminoethoxy)-ethane- 
N N N'N'tetra acetic acid (EGTA)
Guanosine-5'-triphosphate 
Theophylline
Nicotinamide-adenine dinucleotide 
reduced, disodium (NADH)
Cyclic AMP binding protein and 
charcoal
Ethylenediaminetetra acetic acid, 
disodium salt (EDTA)
BDH Chemicals 
Poole
Dorset, UK
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Guanyly1-imi dodiphosph ate
Guanylyl-[gy-methylene]-diphosphate
Adenylyl-imi dodiphosphate
Boehringer (London)
Lewes
East Sussex, BN7 ILG, UK
Serotonin creatine sulphate Ralph N. Emanuel Wembley, UK
Phentolamine 
Cyproheptadine 
Propranolol 
Chlorpromazine 
Phenylephrine
Generously supplied by; 
Dr. D. Pollock 
Pharmacology Department 
University of Glasgow
[8- H]-Adenosine-3'5’-cyclic 
phosphate, specific activity 
30 Ci/mmol
The Radiochemical Centre 
Amersham
Bucks., HP7 9LL, UK
Ficoll Pharmacia (GB) Limited London
AG-1-X8, 200-400 mesh 
ion chloride form
Biorad Laboratories 
C ax ton Way 
Watford, Herts, UK
Schistocerca gregaria
Larujon Locust Suppliers 
Welsh Mountain Zoo 
Colwyn Bay 
North Wales
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Methods
1. Tissue Preparation
Cerebral ganglia were carefully dissected, placed in ice,
/L
cold insect saline (Usherwood et al, 1965) and thoroughly 
washed. The ganglia were then homogenised in 6x10 ^M Tris- 
HCl buffer (pH 7,5) containing 2x10 ^M EGTA (4 ganglia/600 
111) using a glass homogeniser with a motor driven teflon 
pestle. With the exception of sub-cellular fractionation 
experiments (45 ganglia/ml) , the ratio of 4 ganglia/600 jil 
Tris-HCl buffer was maintained throughout all experiments. 
Twenty microlitres of the homogenate (approximately 25 jig 
protein) was then assayed for adenylate cyclase activity.
1.1 Preparation of Crude Membrane Fractions (pf  ^ and pfo)
The p f a n d  pf^ fractions were prepared as shown in 
Figure 6, The homogenate (4 ganglia/600 jil) was 
centrifuged at 9000 g for 10 minutes at 4°C, the 
supernatant discarded and the pellet (pf^ ) was re­
suspended in 600 |il 6x10 ^M Tris-HCl buffer (pH 7.5) 
containing 2x10 ^M EGTA. A pf^ fraction was prepared 
by further centrifugation of a pf^ fraction at 9000 g 
for 10 minutes at 4^C, discarding the supernatant,and 
re-suspending the pellet in 600 p,l 6x10 ^M Tris-HCl 
buffer (pH 7.5) containing 2x10 ^M EGTA, Twenty 
microlitres of either a pf^ or pf^ fraction (approxi­
mately 10 jig protein) was assayed for adenylate 
cyclase activity.
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FIGURE 6
Preparation of pf^ and pf^ Fractions 
from Cerebral Ganglia
Homogenate 
(4 ganglia/600 jj,l) ^
Supernatant Pellet (pf^ )
Supernatant Pellet (pfg)
 ^ Homogenised in 600 p,l 6 mM Tris-HCl (pH 7.5) buffer con­
taining 2 mM EGTA
 ^ Suspended in 600 fxl Tris-HCl (pH 7.5) buffer containing
2 mM EGTA
* Centrifugation at 9000 g for 10 minutes at 4°C
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1.2 Formation of Stable Complex
A pf2 fraction (0.6 ml) prepared as previously des­
cribed was incubated with 0.2 ml of 4x10 Gpp(NH)p
-2
prepared in 8x10 M Tris-maleate buffer (pH 7.5)
“2 -3containing 10 M theophylline, 5x10 M magnesium sul­
phate and 5x10 EGTA for 5 minutes at 30^C, To re­
move unbound Gpp(NH)p, the mixture was centrifuged 
twice at 9 000 g for 10 minutes at 4°C and the final 
pellet re-suspended in 0.6 ml of 6x10 Tris-HCl 
buffer (pH 7.5) containing EGTA (2x10 ^M). Twenty 
microlitres of this pellet fraction was then added 
to the test substance as indicated and adenylate 
cyclase activity measured.
1.3 Sub-cellular Fractionation
Sub-cellular fractionation was carried out by a method 
slightly modified from that of Donnellan et al, 19 76. 
Cerebral ganglia (45 ganglia/ml) were homogenised in 
0.25M sucrose containing Tris-HCl (5x10 M^) (pH 7,5)
_ 3
and EGTA (10 M). After filtration through a nylon 
net (159 jam aperture) to remove gross particulate 
material, the homogenate was centrifuged at 1000 g 
for 10 minutes and the pellet combined with the gross 
particulate material (P^ ) . The supernatant (S^ ) was 
centrifuged at 20000 g for 20 minutes to give a crude 
mitochondrial pellet (P2) and a supernatant (S^).
The Pg pellet was suspended in 1 ml 0.25M sucrose (pH
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FIGURE 7
Süb-cellular Fractionation of Cerebral Ganglia
Homogenate (45 ganglia/ml 0.25M sucrose containing 5x10 Tris-
HCl (pH 7.5) and 10 1^4 EGTA. Passed through nylon net
Residue
Centrifuged for 10 minutes at 
4°C at 1000 g
T
Supernatant (S )Pellet (P
Gradient
Fraction
Centrifuged for 20 minutes at 4°C 
at 20000 q_____
Pellet (Pg) Supernatant (SgJ
Layered onto Ficoll gradient, centrifuged for 
60 minutes at 75000 g at 4°C
F. F
0.25M 
Sucrose/ 
4% Ficoll 
Interface
4-12%
Ficoll
Interface
12- 10 %
Ficoll
Interface
20%
Ficoll
TOP BOTTOM
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7.5) and layered onto a discontinuous gradient com­
posed of 4 ml layers of 4, 12 and 20% (w/v) Ficoll 
containing 0.25M sucrose (pH 7,5). After centrifu­
gation on a swing out rotor for 1 hour at 75000 g at 
4°C, the indicated fractions (Figure 7) were collected. 
Material sedimenting through the 20% Ficoll layer was 
suspended in 0.25M sucrose (pH 7.5).
2. Measurement of Adenosine-3 * 5*-Cyclic Phosphate
Cyclic AMP was measured by the method of Tovey et al, 19 74.
All additions to the assay were prepared in a 5x10 ^M Tris-
HCl buffer (pH 7.5) containing EDTA (4x10 ^M), with the
exception of unlabelled cyclic AMP standards which were
dissolved in 8x10 ^M Tris-maleate buffer (pH 7.5) con-
_2
taining theophylline (10 M), magnesium sulphate (2 or 5x 
10“\) and EGTA (5xlO“ M^) . ^
Fifty microlitres of the samples were added to Eppendorf 
tubes containing initiated cyclic AMP (50 jal, 0.5 |j-Ci/ml) 
and mixed before the addition of binding protein (100 jil) , 
diluted 15 fold with Tris-HCl (5x10 ^M, pH 7.5) containing 
EDTA (4x10 M^) . After mixing the contents, the tubes were 
incubated for 2 hours in an ice bath. To remove the free 
[^H]-cyclic AMP from the bound [^H]-cyclic AMP, 100 jj,l of 
a charcoal suspension (0.1% w/v prepared in Tris-HCl buffer 
[5x10 .^ M] , pH 7.5 containing EDTA [4x10 ^M] and 1% BSA) was 
added to each tube, mixed and then centrifuged at 10000 g 
for 1 minute at room temperature in an Eppendorf bench
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centrifuge. Two hundred microlitres of the supernatant,
3
containing the bound [ H]-cyclic AMP was ' added to*3 ml of 
a toluene-Triton X-100 scintillant prepared by adding 500 
ml Triton-X-100 to 1 litre of toluene containing 19.8 g PPO 
and 1.9 8 g POPOP. Distilled water (0.2 ml) was then added 
to each vial and mixed to obtain a clear solution. The 
radioactivity was determined by liquid scintillation coun­
ting. To prepare a standard curve and to measure the 
charcoal blank, Eppendorf tubes containing the following 
were included in each measurement of cyclic AMP. The stan­
dard curve contained 50 jil unlabelled cyclic AMP (1-16
3
pmoles/assay) , 50 jj.1 [ H]-cyclic AMP and 100 pi binding 
protein. The charcoal blank was prepared by adding 50 pi 
[^H]-cyclic AMP to 150 pi Tris-HCl buffer (5x10 ^M, pH 7.5)
_  3
containing EDTA (4x10 M). One hundred microlitres of the 
charcoal suspension were added to each tube and assayed as 
described previously. The radioactivity determined in 
200 pi of the blank supernatant was subtracted from the 
values observed from the standard curve and unknown samples
The radioactivity bound in the absence of unlabelled 
cyclic AMP was designated from which ratio was
calculated for each concentration of unlabelled cyclic AMP.
A linear relationship was obtained by plotting C^/C^ against 
pmoles of standard cyclic AMP (Figure 8). The amount of 
cyclic AMP in each sample was then determined from the 
corresponding value. A new standard curve was in­
cluded in all measurements of cyclic AMP and each standard 
determined in duplicate.
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FIGURE 8
A Typical Standard Curve for the Measurement
of Cyclic AMP
Xo
u
o
Cyclic AMP (pmoles)
Each determination was carried out in duplicate
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3. Enzyme Assays
3.1 Adenylate Cyclase
Adenylate cyclase activity was measured in an assay
system similar to that described by Harmar and Horn,
19 77 containing as a final concentration, GTP (10 ,
-4ATP (5x10 M), test substance where indicated and 
tissue preparation in a final volume of 80 |il. All 
additions to the cyclase assay (with the exception of 
tissue preparation) were prepared in an incubation 
buffer such that the final concentration in 80 |il was
8x10 Tris-maleate (pH 7.5), 10 theophylline,
-3 -3 -42x10 M or 5x10 M magnesium sulphate and 5x10 M
EGTA, After preliminary incubation of the assay 
system in the absence of ATP for 5 minutes at 30^C,
ATP was added to start the reaction. The samples 
were incubated for 3 minutes at 30^C and the reaction 
terminated by boiling for 3 minutes. The contents of 
each Eppendorf tube were then centrifuged for 5 minu­
tes at 1000 0 g in an Eppendorf bench centrifuge to 
remove denatured protein and 50 jil aliquots of the 
supernatant assayed for cyclic AMP.
For some of the experiments with Gpp(NH)p, the pro­
cedure was modified by initiating the reaction by the 
addition of the tissue preparation.
Adenylate cyclase activity was calculated from the 
following formula:
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(pmoles/min/ml} = cyclic AMP total volume, o f assay
50 pi Incubation timei  tissue volume added to assay
= pmoles cyclic AMP ~  ‘ ^  x 1  x ^
0.050 ^ 3 ^ 0.02
= pmoles cyclic AMP x 26.6
The specific activity was therefore obtained by dividing the value obtained by the 
appropriate rag protein/ml.
3.2 Cyclic AMP Phosphodiesterase
Cyclic AMP phosphodiesterase activity was measured by
a modification of the method of Thompson and Appleman,
19 71. The volume of the assay mixture was 0.4 ml
~ 3which contained, as a final concentration, 5x10 M 
magnesium sulphate, 4x10 Tris-HCl (pH 8.0), 3,75x 
10 ^M 2-mercaptoethanol, 0.1 pCi [^H]-cyclic AMP,
10 ^M cyclic AMP and 0.1 ml of a pf^ preparation 
(approximately 50 |ig protein) . The reaction was in­
itiated by the addition of the pfj^  fraction to the 
mixture also equilibrated to 30*^ C. After incubation 
for 5 minutes at 30*^ C, the reaction was terminated by 
boiling for 45 seconds followed by cooling in an ice 
bath.
5'-Adenosine-monophosphate, the product formed by
cyclic AMP phosphodiesterase, was hydrolysed to ade-
— 5nosine by the addition of 5x10 g of snake venom 
(Ophiaphagus hannah). The tubes were mixed and incu­
bated for 10 minutes at 30^C in a shaking water bath.
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To terminate the reaction, the samples were immersed 
in an ice bath before the addition of 1 ml methanol. 
The entire contents of each tube were transferred to 
AG-1-X8 columns. The columns were then washed with 
1 ml methanol and the eluate added to 10 ml of a 
toluene scintillant prepared by dissolving 19.8 g PPO 
and 1.9 8 g POPOP in 2.5 litres of toluene. The 
radioactivity in the eluate was determined by liquid 
scintillation counting.
Cyclic AMP phosphodiesterase specific activity was 
calculated as indicated:
, , , . cpm (measured - blank) „ pmol substrate 1  1---------
specific activity cpm (maximum) blank 0— 4 ml time mg protein added
3.3 Glutamate Dehydrogenase (L-glutamate; NAD Oxidoreduc- 
tase B.C.1.4.1.3)
Glutamate dehydrogenase activity was measured by a
modification of the method of Donnellan et al, 19 74.
The sub-cellular fractions (0.2 ml) were added to an
—  2assay containing as final concentration 5x10 M Tris- 
HCl (pH 7.,9) , 10 ^M ammonium acetate, 0.1% (w/v) 
Triton-X-100, 2.2xlO"^M NADH, lO’^M ADP and 5xl0"^M 
sodium 2-oxoglutarate in a final volume of 0.5 ml. 
Glutamate dehydrogenase activity was proportional to 
the decrease in absorbance at 3 40 nm due to the oxi­
dation of NADH. The endogenous oxidation of NADH by 
the tissue was followed for 10 minutes in 1 cm micro-
31.
cuvette before the addition of 2-oxoglutarate and the 
change in absorbance AE measured for a further 10 
minutes. The absorbance change due to glutamate de­
hydrogenase was calculated by subtracting the endo­
genous AE from that obtained in the presence of 2- 
oxoglutarate. Thus, from the molar extinction co­
efficient for NADH (6220 litres/mol/cm), the activity 
was calculated from the following equation:
. . .  , , .  1____________  „ assay volume  1____________
nmol/min/ml - ÙE/rain x extinction coefficient light path volume of tissue added
- AE/min x ^^20 ^ 1 ^ 0 . 2 0
= AE/min x 402
The specific activity was calculated by dividing the activity by the appropriate 
mg protein/ml.
3. 4 Glycerol-3-Phosphate Dehydrogenase (L.3-Glycerophos­
phate: NAD Qxidoreductase E.G.1.1.1.8)
Glycerol.-3-phosphate dehydrogenase activity was measured
by a method slightly modified from that of Donnellan
et__ad, 1974 . Sub-cellular fractions (0.1 ml) were
added to an assay containing, as a final concentration 
-2
5x10 M potassium dihydrogen phosphate (pH 6.9), 0.1% 
(w/v) Triton-X-100, 2.5xl0~'^M NADH and 2.5xl0~^M di- 
hydroxyacetone phosphate in a final volume of 0.4 ml.
The change in absorbance (AE) as a result of endo­
genous NADH oxidation was followed for 10 minutes in 
a 1 cm micro-cuvette at 340 nm before the AE, in the 
presence of dihydroxyacetone phosphate was measured 
for a further 10 minutes. Thus, the change in absor­
bance as a result of glycerol—3-phosphate dehydrogenase 
activity was calculated by subtracting the endogenous 
AE from that observed in the presence of dihydroxy-
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acetone phosphate. From the molar extinction co­
efficient for NADH (6220 litres/mol/cm), the activity 
was calculated from the equation shown below.
nmol/min/ml = AE/min x _____ _ x
extinction coefficient light path volume of tissue added
= AE/min x 6 4 3.1
The specific activity was therefore determined by dividing the activity by the appropriate 
mg protein/ml.
3.5 Acetylcholinesterase (E.G.3.1.1.7)
Acetylcholinesterase activity was measured by the 
method of Ellman et al, 1961. Acetylcholinesterase 
hydrolyses acetylthiocholine into acetate and thio- 
choline. The liberated thiocholine reacts with 5,5'- 
dithiobis(2-nitrobenzoic acid) to form thionitro- 
benzoic acid and the colour intensity of this product 
measured at 40 5 nm.
Sub-cellular fractions (0.1 ml) were incubated with,
-2as a final concentration, 2x10 M sodium orthophos­
phate (pH 7.7), 6x10 acetylthiocholine iodide and 
2.5x10 5,5'-dithiobis(2-nitrobenzoic acid) in a
final volume of 2.1 ml in a 1 cm cuvette. The time 
taken (seconds) for an absorbance change correspon­
ding to 0.1 units was measured. From the molar ex-
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tinction coefficient for thionitrobenzoic acid 
(13300 litres/mol/cm), the activity was calculated 
from the equation shown below.
T >   assay volume  1_______   fO_________
nraoles/min/mJ. extinction coefficient light path sample volume time taken forûE (S)
O.I A-x GO
13300 1 0.1 time (S)
9473.7
time (S)
The specific activity was calculated by dividing by the appropriate mg protein/ml.
4. Protein
Protein concentration was;' determined as described by 
Bailley, 1962 ., a modification of the method of Lowry et al, 
1951. Bovine serum albumin was used as the standard pro­
tein and a typical protein standard curve is shown in 
Figure 9.
5. Mounting and Staining Cerebral Ganglia
5.1 Embedding and Sectioning (Chayen and Miles, 1954)
Cerebral ganglia were dehydrated by immersion in in­
creasing concentrations of alcohol, transferred to an 
absolute alcohol-xylene mixture (1:1, v/v) for 30
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FIGURE 9
Standard Curve for the Measurement of Protein
cuu
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Bovine serum albumin (jitg)
Each point was carried out in triplicate and is presented as the 
mean + standard error.
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minutes, followed by xylene alone for a further 30 
minutes. The ganglia were removed and added to 
paraffin wax maintained at 55-66^C. The samples 
were frozen and the blocks cut with a microtome for 
staining.
5.2 Staining
The sections were stained with haematoxylin-eosin as 
described by Gurr, 19 73. The slides were rehydrated 
by immersion in decreasing concentrations of alcohol 
and then stained in concentrated haeraatoxylin for 
5 minutes. After rinsing in tap water, the slides 
were counter-stained in eosin for 1 minute, blotted, 
rinsed in water before dehydrating in alcohol and 
finally immersed in xylene for 5 minutes. The cere­
bral ganglia sections were then photographed and the 
results are shown in Figures 4 and 5.
6. Preparation of AG-1-X8 Columns
AG-1-X8 was washed thoroughly with 0.4M hydrochloric acid, 
water, 0.5M sodium hydroxide, water, 0.5M hydrochloric acid 
and water repeatedly to pH 5,0. The resin was then allowed 
to settle for at least 4 5 minutes before the supernatant 
was decanted and 4 volumes of water added to 1 volume of 
resin. A 1 ml portion was then pipetted into Pasteur 
pipettes plugged at the bottom with non-absorbent cotton 
wool. The efficiency of retention of cyclic AMP was
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3
measured by the addition of 0.1 fiCi [ H]~cyclic AMP pre­
pared in 10 Tris-HCl (pH 8.0) buffer containing 3.75x 
“ 310 M 2-mercaptoethanol. The eluate was collected and the 
radioactivity counted. Under the experimental conditions,
3
[ H]-cyclic AMP represented only 1% of the total counts 
added to the column.
7. Statistics
The Student's "t" test was employed for all statistical 
analysis of the data in this thesis. For paired obser­
vations, the "t" statistic was calculated to test the null 
hypothesis (U^ = Ug) at the 9 5% confidence level where U^
= Ug indicates that Sample A is similar to Sample B. If 
the "t" statistic calculated for any paired samples fell 
outside the accepted range (is greater than), then the 
null hypothesis was rejected in favour of accepting that 
the samples were different i.e. (U^  ^ Ug).
8. % Additivity
The percentage additivity for the activation of adenylate 
cyclase by monoamines was calculated from the equation 
shown below.
activity observed experimentally with monoamines ^ 
% Additivity - tj^goi-etlcal sum of individual monoamine activities
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9. % Inhibition
The percentage inhibition of the monoamine-stimulated 
adenylate cyclase by phentolamine, cyproheptadine and 
chlorpromazine was calculated as follows:
activity in the presence _ activity in the presence
» inhibition = 100- 100 X '  a o t l v A H r l hf ^ n - ^ '
of monoamine of drug or monoamine
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RESULTS
Studies on Crude Homogenate
Preliminary studies showed that homogenates of cerebral ganglia
- 4contain an adenylate cyclase stimulated by octopamine (10 M)
(Figure 10). In three experiments, the mean % stimulation of
adenylate cyclase activity by octopamine alone was 315 + 50 of
basal activity. In the absence of octopamine, the small stimu-
— 5 — 7lation (~130%) by GTP was constant over the range 10 M - 10 M,
-4In contrast, the addition of octopamine (10 M) resulted in 
maximum adenylate cyclase activity at GTP (10 ^M). In three 
experiments, the addition of GTP (10 M^) and octopamine (10 M^) 
resulted in a mean % stimulation of 430 + 62.
In cockroach cerebral ganglia (Harmar and Horn, 1977), the
_ 3
addition of octopamine (0.3 x 10 M) only stimulated adenylate
cyclase activity to 112% of basal activity although a 37 8% in-
— 4crease was observed when both octopamine and GTP (10 M) were 
added to the preparation.
1. Effect of Monoamines
Figure 11 shows that adenylate cyclase activity is in­
creased by dopamine and serotonin. From the dose response
curves of activity against concentration of monoamines,
— 4maximum activity in the presence of GTP (10 M) occurred
— 5 — 5at dopamine (10 M) and serotonin (10 M). In five homo­
genate preparations, the mean maximal % stimulation by 
dopamine and serotonin was 188 + 23 and 132 + 14 respecti­
vely.
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FIGURE 10
Effect of GTP on Basal and Octopamine-Stimulated
Adenylate Cyclase
00
■H
80-
40-
20 -
-3—  4-5 10101010 M
GTP
A homogenate of cerebral ganglia was assayed for adenylate cy­
clase activity in the presence (# ) and absence ( ■ ) of octopa­
mine (10“'^M) and increasing concentrations of GTP. ( □ ) repre­
sents the activity observed in the absence of GTP and octopamine 
(basal activity) and (O ) the activity observed with octopamine 
alone. Each point represents the mean + standard error of three 
separate incubations from one homogenate preparation.
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FIGURE 11
Effect of Octopamine, Dopamine and Serotonin
on Adenylate Cyclase Activity
350
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A crude homogenate of cerebral ganglia was assayed for adeny­
late cyclase activity in the presence of 10 GTP and increa­
sing concentrations of octopamine (•), dopamine (O) and sero­
tonin (□). Results are expressed as a percentage of the adeny­
late cyclase activity observed in the presence of GTP alone 
(34+3 pmoles cAMP/min/mg protein). Points represent the mean + 
standard error of three separate incubations.
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In the presence of GTP (10 M^) and octopamine (10 ^M), ade­
nylate cyclase activity was proportional under all condi­
tions to a protein level of up to at least 1.6 mg protein/ 
homogenate (Figure 12). In all subsequent experiments, 
the initial homogenate protein level was approximately
0.8 mg protein/600 |_il.
The observation that appreciable stimulation of adenylate 
cyclase activity was elicited by octopamine in the absence 
of GTP implied that GTP or some other activator may al­
ready be present in the crude homogenate. The homogenate 
was centrifuged at 9000 g for 10 minutes at 4°C to try 
and remove the endogenous activator(s).
Studies on Washed Pellet Fraction (pf^ )
The effect of washing once with homogenisation medium on 
the octopamine-stimulated adenylate cyclase is shown in 
Table 4. Washing caused a 50% decrease in basal activity 
and a 43% and 32% reduction in the activity observed with 
GTP alone when compared to the corresponding activities in 
the homogenate. The addition of octopamine (10 M^) to the 
pellet fraction in two experiments only resulted in 26% 
and 34% of the activity observed in the homogenate being 
regained. In contrast in the presence of both octopamine 
(10 M^) and GTP (10 , the % recovery was increased to
78% and 79% suggesting that the pellet fraction contained 
appreciable amounts of the original adenylate cyclase and 
that the reduction in adenylate cyclase activity observed
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FIGURE 12
Effect of Homogenate protein levels on 
Adenylate Cyclase Activity
200 1
175 -
150-
C
125- ^
O100 •
o_
75-
0-2 0 6 160 4 0-8 12TO
mg To l'ai protein/homogenate
The effect of increasing homogenate protein level on adenylate
-4cyclase was determined in the presence of buffer (O) , GTP (10 ’M) 
(□) and GTP (10 M^) + octopamine (10 (#). Each point rep­
resents the mean + standard error of three separate incubations.
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with octopamine alone was due to the removal of endogenous 
GTP or another nucleotide.
Comparison of the specific activities of each fraction re­
vealed that washing had resulted in a slight purification 
of adenylate cyclase (Table 4). In the presence of GTP 
and octopamine, an increase of 72% and 56% above the acti­
vity observed in the homogenate was observed in the pellet 
fraction.
The synergistic action of GTP and octopamine on adenylate 
cyclase activity, although present in the homogenate was 
more pronounced in the pellet fraction.
1. ‘ Effect of GTP and Octopamine Concentrations on 
Adenylate Cyclase
If increasing concentrations of GTP and octopamine 
were added to the re-suspended pellet, the largest 
increase in adenylate cyclase activity occurred at 
.GTP (10 .^ M) and octopamine (10 - 10 M^) (Figure
13) .
The effect of varying the GTP concentration at fixed 
levels of octopamine is shown in Figure 14. As the 
octopamine concentration was raised, an increase in 
the maximum stimulation was observed. However, at
— 4 — c
10 M and 10 M octopamine, the concentration of GTP 
necessary to give maximum stimulation was broadened
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FIGURE 13
GTP and Octopamine Activation of Adenylate Cyclase
60 1
p m o le s  c A M P / m i n / m g  p r o t e i n
40 -
30 -
20 -
6 4 •38 5-7
C o n c e n t r a t i o n .  [ M J
A washed pellet fraction (pf^ ) prepared as described in Materi­
als and Methods was assayed for adenylate cyclase activity in 
the presence of increasing concentrations of GTP (O) and octo­
pamine (•). (□) is the activity observed with buffer alone
(basal activity). Each point represents the mean + standard 
error of three separate incubations.
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FIGURE 14
Effect of GTP on Octopamine-Stimulated
Adenylate Cyclase
300 1
250 -
2 0 0 - -
□l
1 0 0 -
50-
GTP c o n c e n t r a t i o n  LM ]
A pellet fraction (pf^ ) was assayed for adenylate cyclase acti­
vity in the presence of increasing concentrations of GTP and
— 5with buffer (•) and buffer + octopamine (10 M) (□), octopamine 
(10 M^) (■) and octopamine (10 M^) (O). Each point represents
the mean + standard error of three separate incubations.
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""4 *"5to 10 M - 10 M. At all concentrations of octopa-
-4mine, any increase in GTP above 10 M resulted in in* 
hibition of adenylate cyclase activity.
2. Effect of Monoamines on Adenylate Cyclase
The stimulation of adenylate cyclase activity by 
octopamine, dopamine and serotonin is shown in 
Figure 15. The maximum level of activity was vari­
able, although the response to octopamine was con­
sistently greater than dopamine and dopamine greater 
than serotonin. In five experiments, the mean % 
maximal stimulation above that observed with GTP
alone was 386 + 52 for octopamine (10 M^) , 216 4- 37
-4for dopamine (10 M) and 141 + 8.8 for serotonin 
(10 M^) . The concentrations that produced half 
maximal activation (Ka) for octopamine (8 jiM) and 
dopamine (10 jiM) were similar. However, the Ka value 
for serotonin (1 p,M) was approximately 10-fold less 
than either octopamine or dopamine.
3. Magnesium/ATP Ratio
Adenylate cyclase activity was also affected by the
magnesium/ATP ratio (Figure 16). If increasing con-
-4centrations of magnesium were added to 5 x 10 M ATP 
and 10 GTP, a steady increase in activity was ob­
served up to a magnesium/ATP ratio of four for up to 
10 octopamine. Any subsequent increase in the
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FIGURE 15
Effect of Octopamine, Dopamine and Serotonin
on Adenylate Cyclase Activity
Adenylate Cyclase Activity 
( %  Stimulation )
300'
200 •
100-
L M3 Monoamines
A pellet fraction (pf^ ) was assayed for adenylate cyclase acti­
vity as described in Materials and Methods in the presence of 
GTP (10 M^) and increasing concentrations of octopamine (#), 
dopamine (O) and serotonin (□). Results are expressed as a 
percentage (%) of adenylate cyclase activity observed in the 
presence of GTP alone (88.4 + 18.5 pmoles cAMP/min/mg protein). 
Each point represents the mean + standard error of three sepa­
rate incubations.
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FIGURE 16
Magnesium/ATP Ratio and Adenylate Cyclase Activity
700 1
600 ■
500 ■
CL_
CP
400 -
300 -
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CmM] Magnesium
A pellet fraction (pf^ ) was assayed for adenylate cyclase acti­
vity in the presence of 5 x 10 ATP, increasing concentrations
of magnesium and with buffer (O) and buffer + octopamine (10 M^)
— 5 —4(O), octopamine (10 M) (■), octopamine (10 M) (•) and octopa-
-3mine (10 M).(a). Each point represents the mean + standard 
error of three separate incubations.
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magnesium/ATP ratio had marginal effect on activity.
In the presence of octopamine (10 ^M), a shift in the
optimum magnesium/ATP ratio for maximum activity to
10 was observed. Higher concentrations of magnesium
led to an inhibition of adenylate cyclase activity.
“3All subsequent assays were incubated with 5 x 10 M 
magnesium.
4,. Effect of Time and Temperature on Adenylate Cyclase
Adenylate cyclase activity in the presence of GTP 
(10 M^) and GTP (10 M^) plus octopamine (10 M^) was 
linear for up to 4 minutes (Figure 17). The effect 
of decreasing the octopamine (Figure 18) and dopamine 
(Figure 19) concentrations from 10 - 10 was to
reduce the rate of cyclic AMP production. At these 
concentrations, octopamine-and dopamine-stimulated 
adenylate cyclase activity was linear for 4 minutes.
In the presence of octopamine (10 "^M) and GTP (10 M^) , 
the optimum temperature for adenylate cyclase acti­
vation was between 35°C and 40°C (Figure 20). If the 
temperature was increased above 40°C, inhibition of 
adenylate cyclase activity was observed. Boiling the 
pellet fraction for 3 minutes before commencement of 
the assay resulted in no adenylate cyclase activity 
being detected. The maximum stimulation of adenylate 
cyclase by GTP (10 M^) and octopamine (10 M^) from a 
pellet fraction,kept at O^ C, declined by 25% over two
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FIGURE 17
Time Course of Adenylate Cyclase Activation
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I n c u b a t i o n  T im e  ( min )
A pellet fraction (pf^ ) was assayed for adenylate cyclase acti­
vity at various times in the presence of buffer ( o ) , buffer + 
GTP (10 M^) (□) and GTP (10 M^) + octopamine (10 (#). Each
point represents the mean + standard error of three separate in­
cubations .
72
FIGURE 18
Octopamine Time Course
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çu
1 000
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500 -
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A pellet fraction (pf^ ) was assayed for adenylate cyclase acti­
vity in the presence of GTP (10 M^) and octopamine (10 M^) (O),
_  . /,«“4octopamine (10 “’m ) (□) and octopamine (10 **M) (#) at various
times. Each point represents the mean + standard error of three 
separate incubations.
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FIGURE 19
Dopamine Time Course
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400
CL
?00
1 Z 4
Incubation Time (mm.)
A pellet fraction (pf^ ) was assayed for adenylate cyclase acti­
vity in the presence of GTP (10 and dopamine (10 M^) (O) ,
-5, -4,dopamine (10 "^M) (□) and dopamine (10 **14) (•) at various times.
Each point represents the mean + standard error of three 
separate incubations.
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FIGURE 20
Effect of Temperature on Adenylate Cyclase Activity
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A pellet fraction (pf^ ) was assayed for adenylate cyclase acti­
vity at increasing temperatures in the presence of buffer (O) 
and buffer + GTP (10 M^) (□) and GTP (10 M^) + octopamine (10 M^)
(•). Each point represents the mean + standard error of three 
separate incubations.
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hours (Figure 21) suggesting that the pellet fraction 
was relatively stable.
5. Sub-cellular Localisation of Octopainine-Stimulated 
Adenylate Cyclase
To study the sub-cellular distribution of octopamine- 
stimulated adenylate cyclase, cerebral ganglia were 
homogenised in 0.25M sucrose containing 5 mM Tris- 
HCl and 1 mM EGTA (pH 7.5) and centrifuged as des­
cribed in Materials and Methods to give a crude mito­
chondrial pellet (?2^‘ This fraction was further 
centrifuged on Ficoll density gradients to produce 
three bands, F^, F^, F^ and a pellet F^.
To characterise the fractions obtained, three enzyme 
activities were measured: glycerol-3-phosphate de­
hydrogenase (GPDH) a soluble enzyme (Hatefi and Stig- 
gal, 19 70), glutamate dehydrogenase (GDH) a mito­
chondrial enzyme (Smith et al, 1975) and acetylcho­
line esterase (AChE) an enzyme suggested to be asso­
ciated with cholinergic membranes (Bachelard, 19 74). 
AChE is not an unequivocal marker for cholinergic 
neurons as it has been reported in glial cells of in­
sect central nervous system (Smith and Treherne, 1965)
Preliminary studies on homogenates of cerebral gan­
glia indicated that GDH activity was affected by ADP 
(Figure 22) and of the ADP concentrations assayed.
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FIGURE 21
Stability of Adenylate Cyclase
A pellet fraction (pf^ ) was assayed for adenylate cyclase acti­
vity in the presence (#) of 10 GTP + 10 octopamine, 
placed on ice and the activity re-measured at 1 and 2 hours.
Each point represents the mean + standard error of three separate 
incubations,
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maximum activity occurred at 1 mM. At this concen­
tration, the apparent Km of 1.1 mM for oxoglutarate 
(Figure 23) was similar to the Km (2 mM) observed for 
GDH in the flight muscle of the fleshfly Sarcophaga 
barbata (Donnellan et al, 19 7 4). With GPDH, an appa­
rent Km of 0.2 mM for dihydroxyacetone phosphate was 
determined (Figure 24). The apparent Km values for 
both enzymes were considerably less than the concen­
trations of oxoglutarate (5 mM) and dihydroxyacetone 
phosphate (2,5 mM) used in the assay.
The activities of the enzymes in the P^ ,^ P2 and S2 
fractions are shown in Table 5, Octopamine-stimulated 
adenylate cyclase, GDH and AChE were enriched in the 
crude mitochondrial fraction (P^). In two experi­
ments, the ?2 fraction accounted for 79% and 96% of 
the octopamine-stimulated adenylate cyclase observed 
in the homogenate, GPDH was not clearly confined to 
the soluble fractions.
Table 6 shows the enzyme activities in the four 
fractions produced by centrifuging the P2 fraction on 
Ficoll gradients, GDPH, the soluble enzyme, was en­
riched in the F^  ^ fraction located at the top of the 
gradient whereas GDH enrichment occurred in F^ at the 
bottom. However, a slight GDH enrichment was also 
observed in F^, AChE was localised in F^ and F2.
The F2 fraction was reported to be the fraction where 
nerve terminals are located (Donnellan et al, 19 76),
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FIGURE 22
Effect of ADP on Glutamate Dehydrogenase Activity
250-
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l/>
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Glutamate dehydrogenase activity v?as measured in a homogenate 
of cerebral ganglia in the presence of increasing concentrations
of 2-oxoglutarate and with 0 {■), 2.5 x 10 M) 
,-3
(O), 5 X  l O ^ ^ M
(o) and ADP (10 M) (•). Each point represents the mean + 
standard error of three separate incubations. The homogenate 
contained 10.0 mg protein/ml.
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FIGURE 23
Glutamate Dehydrogenase
0'02i
[ V J
A reciprocal plot of glutamate dehydrogenase activity [V] 
versus concentration of 2-oxoglutarate, [S] in the presence 
of ADP (10 ^M). The activity was measured in nmoles/min/ml 
and the substrate in mM.
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FIGURE 2 4
Glycerophosphate Dehydrogenase
A homogenate of cerebral ganglia was assayed for glycerophosphate 
dehydrogenase activity in the presence of increasing concentra­
tions of dihydroxy acetone phosphate. The results are shown as a 
reciprocal plot of [V], the activity observed measured in nmoles/ 
min/ml against [S] the concentration of dihydroxy acetone phos­
phate (mM). The homogenate contained 10.0 mg protein/ml.
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The high activity in suggests that some solubili­
sation had occurred during the gradient procedure,
6. Effect of Octopamine and Theophylline on Phosphodi­
esterase
Cerebral ganglia contain an active phosphodiesterase 
which readily hydrolyses cyclic AMP.to adenosine-5'- 
monophosphate. To obtain linear rates of hydrolysis 
of cyclic AMP, unlabelled cyclic AMP (10 M^) was in­
cluded in the assay. Theophylline (10 mI4) present in 
all measurements of adenylate cyclase activity in­
hibits the rate of cyclic AMP hydrolysis by phospho­
diesterase (Figure 25). Phosphodiesterase activity
was independent of octopamine and GTP. At octopamine
 ^ — 3 “5concentration/ of 10 M to 10 M, little difference
in activity in the presence of or absence of GTP 
(10 M^) was observed (Table 7).
Evidence for Separate Receptors for Octopamine, Dopamine 
and Serotonin
The preliminary results show that S. gregaria cerebral 
ganglia contain an adenylate cyclase stimulated by octo­
pamine, dopamine and serotonin in the presence of GTP. To
ivAv/.e.<
-dis-tinguish-between the possibility that separate receptors 
contributed to the cyclase activation, the effect of adding 
the monoamines simultaneously and the effect of monoamine 
antagonists on adenylate cyclase activity was studied.
84
FIGURE 25
Time Course for Phosphodiesterase
A pellet fraction (pf^ ) was assayed as described in Materials 
and Methods for phosphodiesterase activity in the cibsence ( # ) 
and presence ( ■) of theophylline (10 M^) , Each point repre­
sents the mean + standard error of three separate incubations
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TABLE 7
Effect of GTP + Octopamine on Phosphodiesterase
Phosphodiesterase Activity
pmoles/min/mg protein.
Additions Octopamine (10“ 3m )
Octopamine 
(10-4m )
Octopamine
(10“5m ) Buffer
Buffer 4.0* +0.0 7
4.12* 
+0.24
4.12*
+0.16
3.9* 
+0 • 6
GTP (0.1 mM) 3.95*+0.01
3.9*
+0.07
4.02*
+0.11
4.0*
+0.04
* Difference between values not statistically significant
A pellet fraction (pf,) was assayed for phosphodiesterase
- 3 - 4activity in the presence of octopamine (10 M, 10 M and
— 5 —410 M) and in the absence and presence of GTP (10 M).
Each value represents the mean + standard error of three 
separate incubations.
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1. Additive Effects of Octopamine, Dopamine and Seroto­
nin
— 4 —5The addition of dopamine (10 M) or serotonin (10 M)
-4
to octopamine (10 M) resulted in a greater activa­
tion of adenylate cyclase than obtained with octo­
pamine alone (Table 8), Assuming complete additivity, 
then the theoretical activity for any combination can 
be determined. The % additivity can be calculated by 
comparing the experimental value with the theoretical. 
In three separate experiments, the % additivity for 
the addition of dopamine to octopamine was 93, 92 and 
105, for serotonin to dopamine 89, 90 and 213 and 
serotonin to octopamine 116, 115 and 96 suggesting 
the existence of separate receptors for octopamine, 
dopamine and serotonin.
2. Use of Antagonists
Phentolamine, an a-antagonist, propranolol, a 
3“antagonist, chlorpromazine, a dopaminergic anta­
gonist, cyproheptadine, a serotonin and histamine 
antagonist and phenylephrine, an a-agonist were 
tested for their effect on the octopamine-, dopamine- 
and serotonin-stimulated cyclase in re-suspended 
pellets of locust cerebral ganglia. Maximal activity 
was defined as the stimulation obtained with mono­
amines alone and 100% inhibition when the activity 
in the presence of antagonists was reduced to the 
activity observed with GTP (10 M^) in the absence of
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monoamines. The value is the concentration of
antagonist that produces 50% inhibition.
Phentolamine was more potent than propranolol in the 
inhibition of the octopamine-stimulated adenylate 
cyclase (Figure 26). In two experiments, the I^q 
values for phentolamine were approximately 4 and 6 x 
10 and, for propranolol, 1 and 0.8 x 10 In­
hibition of the octopamine stimulation by phenyl­
ephrine was observed at concentrations greater than 
-410
In contrast with the situation for the octopamine- 
stimulated adenylate cyclase, phentolamine and pro­
pranolol were relatively ineffective as antagonists 
of the dopamine response (Figure 2 7). In two experi­
ments, the IgQ value for phentolamine (10 and 0,8 x 
10 "^M) and propranolol (10 and 0.9 x 10 M^) were 
similar. The most potent dopamine antagonist was
“6cyproheptadine with an I^q of approximately 4 x 10 M.
Phenylephrine however gave a more complex pattern.
— 5In two experiments, phenylephrine (10 M) had no 
effect on dopamine stimulation whereas inhibition at 
10 (40%, 30%) and 10 (35%, 20%) was observed.
The small stimulation by serotonin made the interpre­
tation of the effect of antagonists difficult. Phen­
tolamine and propranolol appear to have little effect 
on the serotonin-stimulated adenylate cyclase (Figure 
2 8). Cyproheptadine (10 M^) inhibited serotonin
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FIGURE 26
Antagonism of Octopamine-stimulated Adenylate Cyclase
pmoles cAMP/min/mg protein
5001
400 -
300 -
200 -
100 -
Concentration. [M ]
A washed pellet fraction (pf-, ) was assayed for adenylate cyclase
“4 -4activity in the presence of 10 M GTP -f 10 M octopamine and in 
the absence and presence of increasing concentrations of (O) 
phentolamine, (□) propranolol and (•) phenylephrine. (♦) is 
the activity (4 80 + 50 pmol/min/mg protein) observed with GTP + 
octopamine alone and (O) the activity (125 + 18 pmol/min/mg 
protein) with GTP alone. Each point represents the mean + 
standard error of three separate incubations.
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FIGURE 27
Antagonism of Dopamine-Stimulated Adenylate Cyclase
pmoles r A l i P / m i n / m g  p r o t e in .  
300 1 o
200-
100 -
I
Î
10-7 10'^  10"^  
C o n c e n t r a t io n  CM ]
10 -4 10
A pellet fraction ( p f w a s  assayed for adenylate cyclase acti­
vity in the presence of 10 GTP + 10 dopamine and in the 
absence and presence of increasing concentrations of (O) phen­
tolamine, (□) propranolol, (•) phenylephrine and (■) cypro­
heptadine. (♦) is the activity (260 + 15 pmol/min/mg protein) 
observed with GTP + dopamine alone and «>) the activity (140 + 
10 pmol/min/mg protein) with GTP alone. Each point represents 
the mean + standard error of three separate incubations.
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FIGURE 2 8
Antagonism of Serotonin-Stimulated Adenylate Cyclase
250
200
150-
100 -
50 -
pmoles cAMP/min/mg proPein
10 -7 10-6 10 -5 10•4
"In
Concentration ]
A pellet fraction (pf,) was assayed for adenylate cyclase acti-
-4 -5vity in the presence of 10 M GTP +10 M serotonin and in the 
absence and presence of increasing concentrations of (O) phen­
tolamine, (n) propranolol, (#) phenylephrine and (■) cypro­
heptadine. (♦) is the activity <170 + 14 pmol/min/mg protein) 
observed with GTP + serotonin alone and (O) the activity (12 0 + 
10 pmol/min/mg protein) with GTP alone. Each point represents 
the mean + standard error of three separate incubations.
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stimulation by 100%. Higher concentrations of cypro­
heptadine decreased the activity below that observed 
with GTP alone making it difficult to determine I^q
values. Phenylephrine at concentrations greater than 
-510 M increased adenyl&te cyclase activity above that
observed with serotonin. In two experiments, a 1,2
and 1.3 fold increase was observed with phenylephrine 
— 4(10 M). At this concentration, the stimulation was 
completely additive (Table 9) .
Selective concentrations of phentolamine, cyprohepta­
dine and chlorpromazine were added to an octopamine-, 
dopamine- and serotonin-stimulated adenylate cyclase 
from the same preparation. Table 10 shows that phen­
tolamine (8 ]j.M) allows the preferential inhibition of 
the octopamine response while having little effect on 
the dopamine-stimulated adenylate cyclase. The effect 
on the serotonin response was inconsistent. In con­
trast, chlorpromazine (10 |iM) inhibited the dopamine- 
stimulated adenylate cyclase leaving the octopamine 
response relatively unaffected suggesting that sepa­
rate receptors exist for octopamine and dopamine. 
Cyproheptadine was equally effective at inhibiting 
the octopamine- and dopamine-stimulated adenylate 
cyclase but resulted in a relatively greater inhi­
bition of serotonin-stimulated adenylate cyclase.
This, together with the additive effects of serotonin 
and phenylephrine (Table 9) suggested that a separate 
serotonin receptor, distinct from that of octopamine 
and dopamine may exist in locust cerebral ganglia.
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TABLE 9
Additive Effects of Serotonin and Phenylephrine upon 
Adenylate Cyclase Activity in Pellet Fractions 
of Locust Cerebral Ganglia
Additions
Increase in adenylate 
cyclase activity 
(pmoles/min/mg protein)
Serotonin (10 M^)
, Phenylephrine (10 M^) 
Serotonin + Phenylephrine
40.7 + 2.5 
44.9 + 5.0
91.7 + 10.0
Adenylate cyclase activity was measured in the presence of GTP 
(10 ^M), serotonin (10 M^) and phenylephrine (10 ^M). This 
serotonin concentration elicited maximal increase in adenylate 
cyclase activity when added alone. All values are means + 
standard errors for three separate incubations and represent the 
absolute increase in adenylate cyclase activity above that 
(12 8.8 pmoles/min/mg protein) observed in the absence of sero­
tonin or phenylephrine.
9.4
TABLE 10
Selective Inhibition of Adenylate Cyclase 
Phentolamine (8 p-M)
pmoles cAMP/min/mg protein
g
Buffer Octopamine
(10-4M)
%
Inhibition
Dopamine
( 1 0 " 4 m )
%
Inhibition
Serotonin
( 1 0 - 5 m )
%
Inhibition
154.5 + 22.7 713.0 + 23.3 - 422.0 + 29.1 - 238.0 + 10.2 -
128.8 + 14.2 634.8 + 14.0 - 361.0 + 10.1 - 208.5 + 11.1 -
173.1 + 24.1 340.9 + 2 4 . 1 70 381.2 + 12.1 22 204.7 + 26.7 62
130.1 + 10.0 261.1 + 27.3 74 352.0 + 20.0 5 218.7 + 12.7 0
Cyproheptadine (10 |iM)
pmoles CAMP/min/mg protein
Buffer Octopamine(10-4m )
%
Inhibition
Dopamine
(10“ 4m )
%
Inhibition
Serotonin
(10-5M)
%
Inhibition
152.1 + 18.1 722.9 + 69.2 - 322.4 + 8.3 240.0 + 3.6 -
164.1 + 18.9 597.1 + 43.2 - 438.3 + 9.0 - 190.1 + 2.5 -
163.7 + 17.2 678.8 + 10.0 17 311.3 + 10.3 13 180.0 + 2.5 82
129.5 + 11.3 432.8 + 36.4 30 380.8 + 9.2 8 136.8 + 6.0 72
Chlorpromazine (10 p M )
pmoles
■ ......... ................... '
cAMP/min/mg protein
---------------- ...
r
Buffer ■Octopamine(10“ % )
%
Inhibition
Dopamine
(10"4m )
%
Inhibition
Serotonin
(10"5m )
%
Inhibition
117.4 + 1.8 710.8 + 48.2 - 513.2 + 14.6 169.7 + 9.3 -
140.7 + 13.6 700.0 + 52.1 - 526.0 + 9.8 - ND -
121.4 + 1.8 683.9 + 64.4 5 176.3 + 21.5 86 133.3 + 13.7 78
143.7 + 3.7 655.0 + 35.1 8 260.9 + 6.6 70 ND -
ylat e cyclase activity stimulated in the presence of GTP (10 M ) , octopamine (10 M ) , dopa- 
: (10“ '^ M) and serotonin (10“ ^M) was measured in a washed pellet fraction (pf^) in the absence 
presence of phentolamine (8 |0.M) , cyproheptadine (10 |iM) and chlorpromazine (10 pM) . All 
les are the mean + standard error of three separate incubations and the table shows the re- 
■s of two separate experiments. The % inhibition was calculated as described in Materials 
Methods. ND = not determined.
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Role of Guanyl Nucleotides in the Activation of Adenylate
Cyclase
Locust adenylate cyclase is similar to adenylate cyclase 
from other organisms in its requirement for GTP for acti­
vation in the presence of monoamines. To determine to what 
extent S. gregaria adenylate cyclase is similar to mamm­
alian and avian adenylate cyclase, the effect of two non- 
hydrolysable analogues, Gpp(NH)p and Gpp(CH2)p on adeny­
late cyclase was studied,
1,.. Preliminary Studies
In a washed pellet fraction and in the absence of
monoamines, Gpp(NH)p and Gpp(CH2)p stimulated adeny-
— 4late cyclase activity maximally at 10 M (Table 11). 
The effect of this concentration of Gpp(NH)p and Gpp- 
(CH2)p on adenylate cyclase was compared with GTP 
(Table 12). The stimulation of cyclase activity, 
above that observed with GTP alone, by Gpp(NH)p (10 M^) 
(10 fold) was greater than the 4 fold increase by 
Gpp(CH2)p (10 ^M). The addition of octopamine to the 
guanyl nucleotides, although causing a 3 fold stimu­
lation of cyclase activity with GTP had no effect on 
Gpp(NH)p. With Gpp(CH2)p, however, a small but con­
sistent increase was observed (Table 12). In two ex­
periments , the % increase by octopamine above that 
obtained with Gpp(CH2)p alone was 2 4 and 36. The 
addition of dopamine or serotonin did not result in an 
increase in cyclase activity with Gpp(NH)p
;96
TABLE 11
Effect of GpptCHgïP and Gpp(NH)p on Adenylate Cyclase
Additions
pmoles/cAMP/min/mg protein
Gpp(CH2)p Gpp(NH)p
10” 434.8 + 9.4 410.0 + 20.1
1030,0 + 107.0 
1236.6 + 56.0
—  A
10 M 618.6 + 55.8 534.9 + 9.7
1386.0 + 150.0 
1360.8 + 30.0
"5 10 M 353.1 + 13.2 ND
1091.3 + 103.5 
1049.6 + 41.0
ND - Not determined
A washed pellet fraction (pf^) was assayed for adenylate 
cyclase activity in the presence of increasing concentrations 
of Gpp(CH2)p and Gpp(NH)p. Each value represents the mean + 
standard error of three separate incubations and the results 
shown are for two separate experiments.
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TABLE 12
Effect of Guanyl Nucleotides on Adenylate Cyclase
Additions
pmoles, cAMP/min/mg protein
10 GTP 10"^M Gpp(CH2)p 10”^M Gpp (NH) p
Buffer 138.2 + 14.6 
194.8 + 4.4
519.6 + 45.9 
582.0 + 20.0
1386.1 + 260.3
1139.2 + 58.0
Octopamine
(10-4M)
431.6 + 32.7 
562.8 + 38.6
643.1 + 76.4 
791.0 + 100.0
1279.4 + 63.9 
1226.0 + 85.0
Dopamine
(10"4m )
341.1 + 45.3 
360.9 + 24.0
583.2 + 35.2 
640.1 + 20.0
1064.2 + 118.0
1110.3 + 98.0
Serotonin
(10-5%)
207.6 + 7.5 
277.1 + 20.3
569.7 + 27.9 
620.5 + 19.0
1047.5 + 144.1
1054.6 + 100.1
A washed pellet fraction (pf^) was assayed for adenylate
cyclase activity, stimulated by octopamine (10 ^M), dopa-
4 5mine (10 M) and serotonin (10 M) in the presence of GTP
(10 ^M), Gpp(CH2)p (10 M^) and Gpp(NH)p (10 ^M). Each value 
represents the mean + standard error of three separate in­
cubations and the results shown are for two separate experi­
ments .
.9 8.
The substantial activation of adenylate cyclase acti­
vity by Gpp(NH)p suggested that endogenous octopamine 
or an activator may be present in the preparation.
The pellet fraction was further washed with homo­
genisation medium to try and recover the octopamine 
effect. Washing exposed an octopamine—sensitive com­
ponent (Figure 29) which was inhibited by phentola­
mine (80 fiM) (Figure 30) . Phentolamine however had 
no effect on the residual Gpp(NH)p activity.
2. Time Course
If the pellet fraction was incubated with Gpp(NH)p 
(10 M^) or Gpp(NH)p + octopamine (10 M^) for 5 minu­
tes at 30^C and the reaction started by addition of 
ATP, adenylate cyclase activity was linear for three 
minutes (Figure 31). Salomon et al, 19 75 observed 
that the addition of Gpp(NH)p to hepatic adenylate 
cyclase resulted in a lag in activity which was 
completely abolished by the addition of glucagon. In 
the locust, pre-incubation of the enzyme with Gpp(NH)p 
may have been responsible for the failure to detect 
a lag with Gpp(NH)p activation. The experiment was 
repeated but with the reaction initiated by the 
addition of a pf^ fraction, equilibrated to 30^C, to a 
reaction cocktail containing ATP and Gpp(NH)p (10 M^) 
or Gpp(NH)p (10 M^) + octopamine (10 M^) maintained 
at 30^C. Adenylate cyclase activity was linear for 
3 minutes (Figure 32) but no lag with Gpp(NH)p acti-
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FIGURE 29
Effect of Washing on Gpp(NH)p Activation
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A pellet fraction (pf^) prepared by centrifugation of a crude 
homogenate at 9000 g for 10 minutes at 4 C was further washed 
and each preparation assayed for adenylate cyclase activity in 
the presence of (0) buffer and buffer + (D) 10 4% Gpp(NH)p and 
(Sî) 10”^M Gpp(NH)p + 10"^M octopamine. Each point represents 
the mean + standard error of three separate incubations. ND = 
no activity detected.
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FIGURE 30
Effect of Washing and Phentolamine on Gpp(NH)p Stimulation
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A pf2 and pf^ preparation prepared as described in Materials 
and Methods were assayed for adenylate cyclase activity in the
presence of (H) buffer and buffer +.(■) 8 x 1 0  
(0)
M phentolamine,
10 Gpp(NH)p, (□) 10 Gpp(NH)p + 10 octopamine, (^ ) '
10 Gpp(NH)p + 8 X 10 phentolamine and (®> 10 Gpp(NH)p
-5 -4+ 8 X 10 M phentolamine +10 M octopamine. Each value repre­
sents the mean + standard error of three separate incubations. 
ND = no activity detected.
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FIGURE 31
Time Course for Gpp(NH)p and Octopamine Activation
of Adenylate Cyclase
4000 i
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A pf2 preparation prepared as described in Materials and Methods
was pre-incubated for 5 minutes at 30°C with (O) 10 '^ M Gpp(NH)p
— 4 “~4and (□) 10 M Gpp(NH)p +10 M octopamine and assayed for ade­
nylate cyclase activity at various incubation times. Each 
point represents the mean + standard error of three separate 
incubations.
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FIGURE 32
Time Course for Gpp(NH)p and Octopamine Activation
of Adenylate Cyclase
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A pellet fraction washed twice Cpf2  ^ was assayed for adenylate
cyclase activity at various times. The reaction was initiated
by the addition of the pellet fraction to a cocktail containing
5 X 10“^M ATP and either (O) IQ-^M Gpp(NH)p or (•) 10“^M 
- 4Gpp(NH)p +10 M octopamine. Each point represents the mean + 
standard error of three separate incubations.
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vation was detected. This method was adopted for all 
subsequent assays involving Gpp(NH)p. In addition, 
the incubation time was reduced to 2 minutes.
3. Ka for Gpp(NH)p Activation
From a Linweaver-Burke plot of activity against con­
centration of Gpp(NH)p, an apparent Ka of 2.2 x 10 
was determined for adenylate cyclase in a pf2 prepa­
ration (Figure 33). In three experiments, the Ka
value determined was 2 x 10 ^M, 2.2 x 10 and 7 x
-610 ^M.
4. Formation of Stable Complex
Pre-incubation of a pf2 fraction with Gpp(NH)p (10 
for 5 minutes at 30°C followed by washing twice with 
homogenisation medium resulted in an adenylate cy­
clase whose activity, when assayed in the presence or
absence of Gpp(NH)p was similar (Table 13). If the
-4stable complex was added to GTP (10 M) + octopamine 
(10 ^M), substantial inhibition of the activity when 
compared with the relatively small effect of GTP or 
octopamine alone was observed (Table 14).
If pre-incubation was carried out with GTP (10 "^M) 
and washed twice with homogenisation medium, inhi­
bition of the subsequent Gpp(NH)p stimulation was ob­
served (Table 13) although the activity was regained 
in the presence of Gpp(NH)p + octopamine.
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FIGURE 33
A pellet fraction washed twice (pfg) was assayed for adenylate 
cyclase activity in the presence of increasing concentrations of 
Gpp(NH)p. The results are shown as a reciprocal plot of [V], 
the activity observed measured in pmoles/min against [S], the 
concentration of Gpp(NH)p (jaM) . Each value was determined in 
triplicate and is expressed as activity/tube containing 10.0 jig
protein.
10
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TABLE 13
Formation of Stable Complex
Pre-incubation 
conditions
Adenylate cyclase activities 
(pmol/min/mg protein) 
in the presence of
Buffer Gpp(NH)p (10"^M)
Gpp(NH)p (lO'^M) 
+ octopamine 
(10-4%)
No addition NANA
618.9 + 12.7
744.9 + 22.0
881.5 + 25.3 
1180.0 + 74.6
GTP (lO'^M) NA
NA
^415.5 + 17.5 
^518.2 + 54.3
^886.8 + 28.9 
%1043.9 + 55.1
Gpp(NH)p 
(10-4M)
839.2 + 68.5 
885.5 ±  50.0
^894.4 + 22.5 
‘'1021.6 ±  48.4
2891.5 + 48.9 
21074.5 + 26.9
NA = Not detected
superscript numbers indicate the significance 
bation with GTP (10” M^) and Gpp(NH)p (10“^M):
The 
incu
of pre-
p > 0.001
not significant 
0.002 < p < 0.01 
0.005 < p < 0.001
A pf2 fraction was pre-incubated with GTP (10 M) and Gpp(NH)p 
(10“ M^) for 5 minutes at 30°C, washed twice with homogenising 
medium at 9000 g for 10 minutes and assayed for adenylate cyclase 
activity in the presence of Gpp(NH)p (10“ M^) and Gpp(NH)p (10"“^ M) 
+ octopamine (10”^M). Each value represents the mean + standard 
error of three separate incubations and the results shown are for 
two separate experiments.
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Figure 34 shows the time course for the inhibition of 
Gpp(NH)p activation observed in an enzyme preparation 
pre-incubated with GTP. If pre-incubation was 
carried out in the absence of GTP and washed, the 
subsequent stimulation by Gpp(NH)p was linear for 
2 minutes. In contrast, pre-incubation with GTP 
under identical conditions gave rise to a biphasic 
time course. Although linear for 2 minutes, the 
activity was less than the preparation pre-incubated 
in the absence of GTP. A marked increase in the rate 
of cyclic AMP production was observed after 2 minutes 
before a final decrease in activity above 3 minutes. 
The addition of Gpp(NH)p (10 + octopamine (10
to this preparation resulted in a biphasic acti­
vation. The activity after an initial "burst" was 
followed by a constant slower rate.
A possible explanation for the lag observed, in a 
preparation pre-incubated with GTP, is that GTP is 
hydrolysed to GDP which remains tightly bound to the 
enzyme even after washing. The lag represents the 
time taken for Gpp(NH)p to replace GDP. Figure 35 
shows the effect of pre-incubation of a pf2 fraction 
with increasing concentrations of GDP, washing twice
w
with homogei^tion medium and measuring the activity 
in the presence of Gpp(NH)p (10 '^M) . In two experi­
ments, incubating with GDP (10 and 10 produced
a lag with subsequent Gpp(NH)p activation.
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FIGURE 34
Effect of Pre-Incubation with GTP on
Time Course of Gpp(NH)p Stimulation
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Time (min)
A pf2 preparation pre-incubated with buffer + GTP (10 M^) for 
5 minutes at 30^C was washed twice at 9000 g for 10 minutes at 
4°C. To the preparation pre-incubated with buffer, adenylate 
cyclase activity was measured in the presence of Gpp(NH)p 
(10”'^M) ( □ ) and Gpp(NH)p (lO^^M) + octopamine (IO^^m) ( ■ ) and
for pre-incubation with GTP (10“^M), activity was measured with 
Gpp(NH)p (10“'^M) (•) and Gpp(NH)p (10“'^M) + octopamine (10“ M^)
{O ). Each point represents the mean + standard error of three 
separate incubations.
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FIGURE 35
Effect of Pre-Incubation with GDP on Time Course
of Gpp(NH)p Stimulation
15001
1000- g
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A pellet fraction (pf^ ) was incubated with (O) buffer and 
buffer + {•) lO'^M GDP, (□) 10"^M GDP and (■) 10”^M GDP for 
5 minutes at 30°C washed as described in Materials and Methods 
and assayed for adenylate cyclase activity in the presence of 
10 ^M Gpp(NH)p. Each point represents the mean + standard 
error of three separate incubations.
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5, Effect of GDP on Adenylate Cyclase
GDP inhibited the Gpp(NH)p and Gpp(NH)p + octopamine” 
stimulated adenylate cyclase at 10 and 10 
(Table 15). In two experiments, a % inhibition of 9 6 
and 95 for Gpp(NH)p (10 M^) and 75 and 83 for Gpp(NH)p 
(10 M^) + octopamine (10 M^) was observed with GDP
-  3
(10 M). The concentration of GDP that was respon­
sible for 50% inhibition of both responses was
-  4
approximately 10 M. No inhibition was observed with 
either 10“^M or lO^^M GDP.
The addition of GDP (10 M^) to the preparation re­
sulted in a consistent stimulation of adenylate 
cyclase above the basal level. In two experiments, 
the % stimulation by GDP (10 M^) vjas 2 83 and 186 
values which were similar to the stimulation observed 
with GTP (lO'^M) (270 and 150).
Interpretation of the effect of GDP on adenylate 
cyclase activity is complicated by the suggestion 
that ATP can act as a substrate for the conversion of 
GDP to GTP (McSwigan et al, 1980). ATP was replaced 
by adenylylimidodiphosphate, a structural analogue of 
ATP containing nitrogen substituted for oxygen before 
the terminal phosphate. This nucleotide was only 
slowly hydrolysed by rat liver membranes and acted as 
a substrate for adenylate cyclase (Rodbell et al, 
1971). In the presence of App(NH)p (10 ^M), the
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addition of GDP (lO'^M) and GDP (10” M^) inhibited the 
Gpp(NH)p and Gpp(NH)p + octopamine-stimulated adeny­
late cyclase (Table 16). In contrast to ATP as sub­
strate for adenylate cyclase, no stimulation was ob-
-4served with GDP (10 M). However, substantially 
lower activities and % stimulations were also ob­
served.
In the presence of App(NH)p, the adenylate cyclase 
sensitive to octopamine and GTP was still present 
(Table 17). In two experiments, the addition of
-4
octopamine to GTP (10 M) resulted in a % increase of
75 and 187 above that observed with GTP alone. In
-4contrast, the addition of octopamine to GDP (10 M) 
resulted in only a 17% and 5% increase in activity, 
an increase that was less than that observed with 
octopamine alone. The small stimulation of adenylate 
cyclase by octopamine and GDP suggests that GDP may 
prevent the coupling between adenylate cyclase and 
the receptor, when App(NH)p is used as substrate for 
adenylate cyclase.
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TABLE 17
Effectiveness of Guanylnucleotides in Restoring Octopamine 
Sensitivity when App(NH)p is Substrate
Guanyl Nucleotide 
added
Adenylate cyclase 
activity 
(pmol/min/mg protein)
Increase due 
to
octopamine 
% increaseNo addition + Octopamine (10-4%)
19.2 + 1.4 ^24.3 + 0.1 26
None
21.2 + 0.5 127.4 + 1.8 28
-  4 14.4 + 0.5 ^16.9 + 0.6 17
GDP (10 M^)
13.7 + 3.4 ^14.5 + 0.6 5
- 4 15.8 + 0.7 ^27.7 + 1.8 75GTP (10 M^)
11.7 + 2.1 ^33.6 + 7.2 187
The superscript numbers indicate the significance of the 
octopamine stimulation:
 ^ = 0.05 < p < 0.025 
= 0.02 < p < 0.01
= 0.005 < p < 0.001
= p > 0.001
= not significant
- 4Adenylate cyclase activity stimulated by octopamine (10 M) 
was assayed with App(NH)p (lO^^M) and in the presence of GDP 
(10"'^ M) and GTP (10“ M^) in a pellet fraction washed twice 
(pf2). Each value represents the mean + standard error of 
three separate incubations and the results shown are for two 
separate experiments.
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DISCUSSION
Monoamine-Stimulated Adenylate Cyclase
Several studies have now shown that invertebrate nervous 
tissue contains adenylate cyclases, stimulated by monoamines 
(Nathanson and Greengard, 19 73; Harmar and Horn, 1977;
Robertson and Osborne, 19 79). This thesis has studied the 
monoamine-sensitive adenylate cyclase of locust nervous tissue 
and the results will now be discussed in relation to work on 
adenylate cyclases in invertebrate and vertebrate tissue. The 
discussion, however, will not be confined to the CNS since most 
vertebrate work has been carried out on either the rat liver or 
turkey erythrocyte enzyme.
The present work clearly demonstrates that S. gregaria cerebral 
ganglia contains an adenylate cyclase that is stimulated by 
octopamine, dopamine and serotonin. The locust adenylate 
cyclase is similar to the enzyme in cockroach thoracic ganglia 
(Nathanson and Greengard, 19 73) since dopamine was approximately 
half as effective as octopamine. Furthermore, although both 
enzymes were activated by serotonin, the magnitude of the 
maximal stimulation (170%) in the cockroach (Nathanson and 
Greengard, 1973) and locust (132 + 14%) was small when compared 
with the 400% and 430 + 62% observed respectively for octopamine 
This, together with the failure of Harmar and Horn, 19 77 to 
detect an effect of serotonin on adenylate cyclase from 
cockroach cerebral ganglia at concentrations as high as 1 mM, 
suggests that serotonin has only a minor effect on this enzyme
116
in insects. In contrast to insects, the activation of adeny­
late cyclase by serotonin in lobster skeletal muscle (Battelle 
and Kravitz, 19 78) and the cerebral ganglion of the earthworm 
Lumbricus terrestris (Robertson and Osborne, 1979) was greater 
than that due to octopamine.
Cockroach thoracic ganglia adenylate cyclase responded to octo­
pamine concentrations as low as 0.03 jxM, was maximally stimu­
lated to 30 )iM and had a Ka of approximately 1.5 |xM (Nathanson 
and Greengard, 19 73). This Ka value was similar to the Ka 
(8 jxM) observed in the locust (Figure 33),
The effect of chemical modification of octopamine on the stimu­
lation of adenylate cyclase from cockroach cerebral ganglia has 
been studied (Harmar and Horn, 19 7 7). The naturally occurring 
D(-) isomer of octopamine was approximately 200 times more po­
tent than the L(+) isomer in activating adenylate cyclase. The 
presence of a 3-hydroxyl group was essential for activity 
and the absence of a p-hydroxyl group reduced the effectiveness 
of activation, although other groups (e.g. fluoro) could re­
place the p-hydroxyl group. The presence of a m-hydroxyl group 
and a m-methyl group reduced activity. Alpha méthylation of 
octopamine resulted in a 60 fold decrease in potency whereas N- 
methylation resulted in only a slight reduction in potency.
The stimulation of adenylate cyclase by octopamine in this 
study and in cockroach thoracic (Nathanson and Greengard, 19 75) 
and cerebral ganglia (Harmar and Horn, 1977) was achieved using 
DL-octopamine. Thus, the concentration observed for stimu­
lation of adenylate cyclase is an over-estimation by a factor
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of 2. In this thesis, the effect of chemical modification of
octopamine was not examined.
1. Characterisation of Octopamine Receptors
There was no obvious similarity between the structures of 
the various drugs found to be potent antagonists of the 
octopamine-stimulated adenylate cyclase in cockroach 
cerebral ganglia (Harmar and Horn, 1977). Thus, the most 
effective octopamine antagonists were cyproheptadine (a 
potent histamine and serotonin antagonist), phentolamine 
(an imidazoline with potent a-adrenergic blocking acti­
vity) and promethazine (a phenothiazine with histamine 
blocking activity). The observation in the cockroach 
(Nathanson, 19 76) and locust (Figure 24) that phentolamine 
was a potent inhibitor of octopamine-stimulated adenylate 
cyclase whereas propranolol, a 3""antagonist, was relatively 
ineffective, suggested that octopamine was acting through 
a-receptors. However, the finding that the a-adrenergic 
agonist phenylephrine was only a relatively weak activator 
of adenylate cyclase (Table 9) indicates that the octopa­
mine receptor may have characteristics different from 
those of classical a-adrenergic receptors. A detailed 
pharmacological investigation in insects may provide 
evidence for the existence of multiple a-receptors similar 
to those observed in vertebrates (Snyder and Goodman, 19 80)
118'
2. Evidence for Separate Receptors
2,1 Additive Experiments
The effects of octopamine, dopamine and serotonin on 
the stimulation of cyclic AMP formation in the locust 
cerebral ganglia were completely additive which 
suggests that each monoamine acts via separate recep­
tors. This is in agreement with reports that the 
stimulation of adenylate cyclase by these amines was 
additive in cockroach thoracic ganglia (Nathanson and 
Greengard, 19 73) and additive with octopamine and 
dopamine in cockroach cerebral ganglia (Harmar and 
Horn (1977), However, stimulation by noradrenaline 
was not additive in either cockroach thoracic (Nath­
anson and Greengard, 19 73) or cerebral ganglia (Har­
mar and Horn, 19 77) which suggested the absence of a 
separate receptor. Furthermore, in cockroach thora­
cic ganglia (Nathanson and Greengard, 19 73), the Ka 
for noradrenaline (30 |iM) was considerably greater 
than that observed for octopamine (1.5 jrM) . Thus, 
the stimulatory effect of noradrenaline on adenylate 
cyclase activity was attributed to a partial acti­
vation of the receptor sites for octopamine, dopamine 
or serotonin. The effect of noradrenaline on locust 
adenylate cyclase was not examined. Additivity was 
also reported for serotonin and octopamine in the 
cerebral ganglia of Lumbricus terrestris (Robertson 
and Osborne, 19 79) although no dopamine-stimulated
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adenylate cyclase could be detected. The failure to 
detect a dopamine-sensitive adenylate cyclase in the 
cerebral ganglia of L. terrestris, a tissue known to 
contain dopamine (Gardner and Cashin, 19 75) suggests 
that not all the actions of dopamine (and likewise 
octopamine and serotonin) necessarily involve an al­
teration of cyclic AMP levels. Thus, in inverte­
brates, receptors, analogous to the vertebrate dopa­
mine and D2 receptors (Kebabian and Caine, 19 79) 
may exist. In the moth Mamestra configurata, dopa­
mine-stimulated adenylate cyclase activity increased 
up to a concentration of 3 jiM, remained relatively 
constant to 10 and then rose again to a maximum at 
100 fiM (Bodnaryk, 1979) . The addition of 100 fxM 
dopamine to a saturating concentration of octopamine 
(40 p.M) did not result in additivity. If, however, 
the dopamine concentration was reduced to 3 p,M, addi­
tivity was observed. It was suggested that for dopa­
mine concentrations up to 10 p.M, the stimulation of 
activity was attributed to specific activation of 
dopamine-sensitive adenylate cyclase, whereas the 
further increase in activity between 10 and 10 0 |llM was 
due to the effect of dopamine on the octopamine- 
sensitive enzyme. In contrast to M. configurata, 
dopamine stimulation of adenylate cyclase in the lo­
cust resulted in only one maximal level of activation 
(Figure 15) .
1 2 0
2.2 Use of Agonists and Antagonists
Studies with agonists and antagonists have provided 
additional evidence for separate receptors in insect 
nervous tissue. For example, in cockroach thoracic 
ganglia, a lower concentration of phentolamine (K^  = 
0,4 fiM) was required to inhibit octopamine-stimulated 
adenylate cyclase than was required for dopamine (K^
= 5 p,M) or serotonin (K^  = 6 jiM) (Nathanson, 19 76) . 
Phentolamine (8 p.M) added to locust adenylate cyclase 
inhibited the octopamine- or dopamine-stimulated 
adenylate cyclase by 70% and 22% respectively. Fur­
ther evidence that phentolamine has little effect on 
dopamine receptors was provided by the observation 
that in rat nucleus accumbens, phentolamine failed to 
antagonise the dopamine stimulation (Watling et al,
19 79) whereas fluphenazine and flupenthixol were both 
potent antagonists. In cockroach brain, flupenthixol, 
although an antagonist of the octopamine-stimulated 
adenylate cyclase (Harmar and Horn, 19 7 7), was a more 
potent antagonist of the dopamine-stimulated adeny­
late cyclase.
Chlorpromazine (Miller and Iversen, 19 74) and halo- 
peridol (Kebabian et al, 1972} Nakahara, 1978) inhi­
bit dopamine-sensitive adenylate cyclase in rat brain 
and in canine caudate nucleus (Sano et al, 19 79), In 
cockroach thoracic ganglia, haloperidol inhibited 
both dopamine (K^  = 0.2 jiM) and serotonin (K^  = 0.5 |u.M)
1 2 1
stimulation at lower concentrations than that requi­
red for octopamine (K^  = 10 p,M) (Nathanson, 19 76) .
In the locust, chlorpromazine (10 jrM) selectively 
inhibited dopamine stimulation but had negligible 
effect on octopamine stimulation (Table 10). This 
finding, together with the selective inhibition of 
octopamine-stimulated adenylate cyclase by phentola­
mine, suggests the existence of separate receptors 
for octopamine and dopamine.
LSD, BOL and, to a lesser extent, cyproheptadine, 
were highly potent antagonists of serotonin stimu­
lation of adenylate cyclase in cockroach thoracic 
ganglia (Nathanson and Greengard, 19 74). The small 
stimulation of locust adenylate cyclase by serotonin 
made interpretation of the effect of antagonists 
difficult. However, cyproheptadine (10 pM) although 
inhibiting octopamine (30%, 17%), dopamine (13%, 8%) 
and serotonin (82%, 72%) stimulation appeared to 
cause a greater % inhibition of the serotonin stimu­
lation (Table 10) suggesting the possibility of a 
separate serotonin receptor.
In conclusion, the preferential inhibition of octopa­
mine and dopamine-stimulated cyclase by phentolamine 
(8 |rM) and chlorpromazine (10 |iM) respectively and 
the inhibition of serotonin response by cyprohepta­
dine (10 |iM) together with the ability of the mono­
amines to stimulate additively in the presence of
1,2 2
saturating concentrations, suggest that activation of 
locust adenylate cyclase by monoamines occurs via 
separate receptors.
Role of Neurotransmitters/Hormones and Guanyl Nucleotides in 
the Regulation of Adenylate Cyclase
Investigations on adenylate cyclase from a variety of sources, 
suggest that regulation of this enzyme is complex involving at 
least three macromolecular components} the catalytic moiety 
separate from the receptor, and a guanine nucleotide binding 
protein (MacGuire et al, 1977). Furthermore, it has been 
suggested that more than one guanine nucleotide site is in­
volved in regulation of hormonal stimulation of the enzyme} 
one regulating the catalytic unit and another the activity of 
the receptor (Iyengar et al, 1979). Thus for the rat liver 
enzyme, guanine nucleotides influence the coupling of the nu­
cleotide binding protein with the catalytic moiety and also 
the binding of glucagon to the receptor. The requirement for 
guanine nucleotides in the activation of locust adenylate 
cyclase was studied to provide further comparison between the 
locust enzyme and adenylate cyclase(s) from a variety of 
sources. Before discussing the results obtained with guanine 
nucleotides in relation to current views on the regulation of 
adenylate cyclase and the involvement of GTP-ase, the similar 
effects of guanine nucleotides on locust and other adenylate 
cyclases will be described.
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1. Activation by Guanine Nucleotides
The present work clearly demonstrates that guanine nucleo­
tides have a pronounced effect on S. gregaria adenylate 
cyclase. Furthermore, the finding that in the presence of 
GTP, activation of locust adenylate cyclase by the stimu­
latory ligands was synergistic, indicates that the locust 
adenylate cyclase is similar to the enzyme present in rat 
liver (Rodbell et al, 1971) , striatum (Chen et al, 1980) 
and turkey erythrocyte (Sevilla et al, 1976) , This syner­
gism was greatly increased by washing, suggesting that GTP 
could replace the removed endogenous activator(s) and 
hence supports the idea that agonist activation of adeny­
late cyclase depends upon guanine nucleotides (Rodbell et 
al, 1979). Further evidence that GTP is an endogenous 
activator of adenylate cyclase was provided by the finding 
that repeated washing of rabbit cerebellum (Cote et al,
19 80) and rat striatum (Chen et al, 1980) abolished the 
isoproterenol and dopamine sensitivities of their respec­
tive cyclases. Neurotransmitter sensitivity was restored 
by the addition of GTP, isolated from the soluble fraction.
In order to study in more detail the role of GTP in the 
activation of adenylate cyclase, the non-hydrolysable GTP 
analogues Gpp(NH)p, Gpp(CH2)p and GTP(y)S have been used 
(Schramm and Rodbell, 19 75} Kaslow et al, 1978} Svobedo 
et al, 1978} Birnbaumer ,.et al, 1980). This study shows 
clearly that Gpp(NH)p is a potent activator of locust 
adenylate cyclase and that Gpp(NH)p is more effective than
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GpptCH^)?. This order of effectiveness of the guanine 
nucleotides i.e. Gpp(NH)p > GppfCHgjp > GTP is similar to 
that observed in rat liver (Birnbaumer et al, 1980). The 
stimulation of locust adenylate cyclase by Gpp{NH)p was 
not dependent upon the addition of either octopamine, 
dopamine or serotonin. This suggested that an endogenous 
stimulatory ligand(s) may be bound to the receptors. In­
deed, further washing of the membrane fraction did reveal 
an octopamine-dependent activation of adenylate cyclase 
(Figure 29), However, the residual activity observed with 
Gpp(NH)p alone is unlikely to be due to endogenous octo- 
pamine as it was not affected by 8x10 M phentolamine, a 
concentration which reduced greatly the octopamine-depen- 
dent activation of adenylate cyclase. Therefore, in lo­
cust cerebral ganglia, two pools of adenylate cyclase, 
one dependent on octopamine and Gpp(NH)p and another de­
pendent only on Gpp(NH)p may exist. In rat hepatic mem­
branes, Gpp(NH)p activated adenylate cyclase in the ab­
sence of glucagon (Salomon et al, 19 74) whereas in turkey 
erythrocyte, activation by Gpp(NH)p was not observed 
(Sevilla et al, 1976). In pigeon erythrocyte membranes, 
pre-treatment with isoproterenol and GMP was a necessary 
step prior to the solubilisation of a nucleotide regula­
tory protein involved in adenylate cyclase activation 
(Pfeuffer and Helmreich, 1975) suggesting that the lack of 
effect of Gpp(NH)p may be related to tightly bound endo­
genous nucleotides. Pre-treatment of turkey erythrocyte 
membranes with isoproterenol and GMP resulted in a sub­
stantial activation by Gpp(NH)p alone (Lad et al, 1980),
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Thus, the results with Gpp(NH)p would suggest that the 
locust enzyme is similar to the enzyme in liver and turkey 
erythrocyte membranes cleared of endogenous nucleotides.
2. Formation of Stable Complex
Adenylate cyclase incubated with Gpp(NH)p or GTP(y)S re­
tains its activity even after extensive washing (Schramm 
and Rodbell, 19 75} Lefkowitz and Caron, 197 5} Northup and 
Mansour, 19 78). This implies that a stable enzyme is 
formed, possibly due to tight binding of the nucleotides. 
In contrast, Gpp(CH2)p failed to form a stable complex in 
the liver fluke Fasciola hepatica (Northup and Mansour, 
1978) which suggests that Gpp(CH2)p dissociates more 
rapidly from the guanine nucleotide site than either 
Gpp(NH)p or GTP(y)S. This interpretation is also con­
sistent with the finding that Gpp(NH)p was more effective 
than Gpp(CH2)p in activating locust adenylate cyclase.
Gpp(NH)p activation of locust adenylate cyclase was re­
sistant to washing. Moreover, the washed enzyme, pre­
activated with Gpp(NH)p was susceptible only to a small 
further activation by Gpp(NH)p or Gpp(NH)p + octopamine. 
This indicated that full activation by the nucleotide had 
occurred and that a negligible amount of bound Gpp(NH)p 
had been removed by washing. Thus, locust adenylate cy­
clase is similar to the enzyme in pancreas (Svoboda et al, 
1978), liver (Birnhaumer et al, 1980, frog erythrocyte 
(Schramm and Rodbell, 1975) and Fasciola hepatica (Northup 
and Mansour, 197 8).
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3. Role df GDP in Adenylate Cyclase Regulation
The finding that Gpp(NH)p was more.efficient than GTP in 
activating adenylate cyclase from a variety of sources 
suggests that hydrolysis of GTP is important in the regu­
lation of adenylate cyclase. The results obtained in this 
study will now be discussed together with the evidence for 
GDP termination of cyclic AMP synthesis.
3.1 Catecholamine-Stimulated GTP-ase
The failure of GTP to form a stable enzyme complex 
{Cautrecasas et al, 1975} Schramm and Rodbell, 1975) 
has led to the suggestion that GTP is hydrolysed at 
the guanine nucleotide site and that the GDP formed 
inhibits the enzyme (Cassel and Selinger, 1976).
The observation that GDP competitively inhibited 
Gpp(NH)p activation of liver adenylate cyclase 
(Salomon et al, 1975} Lin et al, 1978) supports this 
hypothesis and suggests that a GTP-ase may be impor­
tant in the. regulation of adenylate cyclase. Cassel 
and Selinger, 197 7 while studying the catecholamine- 
activated adenylate cyclase in turkey erythrocyte 
membranes observed a catecholamine-stimulated GTP-ase 
whose activity was blocked upon the addition of 
GTP(Y)S and catecholamines. This suggested that the 
hydrolysis of GTP takes place at the regulatory 
guanine site. On the assumption that the hydrolysis 
of GTP to GDP + Pi inhibits adenylate cyclase
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activity, Cassel and Selinger, 19 77 proposed the 
following model to show how a hormone can increase 
adenylate cyclase activity and enhance the hydrolysis 
of GTP at the regulatory site (Figure 36).
Adenylate Cyclase 
bound GTP 
(active)
Hormone "turn off" reaction GTP-ase
GTP \  /  ^GDP.Pi
Adenylate Cyclase 
(inactive)
FIGURE 36
Model for Regulation of Adenylate Cyclase 
(Cassel and Selinger, 1977)
Adenylate cyclase in the presence of hormone and GTP 
oscillates constantly between inactive and active 
states. The function, therefore, of the hormone is 
to enhance the formation of an active adenylate cy­
clase - GTP complex. Thus, persistent activation of 
adenylate cyclase is observed with Gpp(NH)p and 
GTP(y)S as these analogues are not hydrolysed by the 
GTP-ase.
128
3.2 Cholera Toxin
Further evidence to support a role for a GTP-ase in 
the control of adenylate cyclase has been provided by 
studies involving cholera toxin.. This toxin, produced 
by Vibrio cholerae has its diarrhoeic effects by 
activating small intestinal adenylate cyclase (Scha­
fer et al, 1970} Sharp and Hynie, 1971). Cholera 
toxin has been observed to stimulate adenylate cyclase 
from a wide variety of intact cells and tissue 
(Finkelstein, 1973). The effectiveness of cholera 
toxin in stimulating adenylate cyclase appears to be 
due to the fact that the primary recognition site on 
the cell for the toxin is the ubiquitous GMj^  ganglio- 
side in plasma membranes (Cautrecasas, 19 73a, 1973b, 
1973c, 1973d} Moss et al, 1976). An understanding of 
the mechanism of action of cholera toxin was gained 
when it was observed that the guanine binding protein 
was ADP-ribosylated (Cassel and Pfeuffer, 1978). This 
modification inhibited GTP-ase hydrolysis and, there­
fore, by preventing the formation of GDP maintained 
the enzyme in an active configuration. Furthermore, 
following cholera toxin treatment of turkey erythro­
cytes (Cassel and Selinger, 1977b), mouse neuroblas­
toma (Levison and Blume, 19 77) and rat liver (Birn­
baumer et al, 19 80) adenylate cyclase, GTP activation 
resembled that observed with Gpp(NH)p in untreated 
membranes suggesting that GTP-ase action was import­
ant in the regulation of adenylate cyclase.
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3,3 Effect of GDP on Adenylate Cyclase
The observation that GDP was equally effective as GTP 
in potentiating hormone or neurotransmitter stimu­
lation of adenylate cyclase from rat liver (Kimura 
and Nagata, 1977) , rat striatum (Chen et al, 1980} 
McSwigan et al, 1980) and rabbit cortex (Cote et al, 
19 80) suggested that an ATP-dependent transphosphory-
lase reaction resulting in the formation of GTP from
-4GDP was present. The result that GDP (10 M) was
-4equally as effective as GTP (10 M) in increasing lo­
cust basal adenylate cyclase activity is consistent 
with this explanation. If ATP was replaced by 
App(NH)p, a substrate for adenylate cyclase but not 
for the transphosphorylase reaction, activation of 
locust adenylate cyclase by octopamine and GTP was 
observed. However} in the presence of GDP, octopa­
mine-stimulated adenylate cyclase activity was con­
siderably reduced. Thus, locust adenylate cyclase 
is similar to the enzyme in rat striatum (Chen et al, 
19 80} McSwigan et al, 19 80) and rabbit cortex (Cote 
et al, 19 80) in that, in the presence of App(NH)p,
GDP can prevent subsequent stimulation by agonists.
When App(NH)p was used as a substrate for locust 
adenylate cyclase, an approximate 10 fold reduction 
in activity was observed. Similarly, adenylate cy­
clase activity in the presence of App(NH)p at pH 7.5 
was approximately 50% of that observed with ATP in
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plasma membranes from rat fat pads (Rodbell, 1975). 
The difference in activity with ATP and App(NH)p was 
suggested to be due to a pH optima difference. Thus, 
at pH 7.5, the proportion of protonated App(NH)p is 
greater than protonated ATP. Furthermore, protonated 
ATP and App(NH)p were shown to be potent inhibitors 
of rat liver adenylate cyclase. The difference in 
activity between locust and rat fat pad adenylate 
cyclase in the presence of App(NH)p may be due to a 
lower for protonated App(NH)p with the locust 
adenylate cyclase compared with the fat pad enzyme.
Further evidence for an involvement of GDP in the 
regulation of locust adenylate cyclase was provided 
by the finding that GDP inhibited Gpp(NH)p or 
Gpp(NH)p + octopamine activation irrespective of 
whether ATP or App(NH)p was used as the substrate.
GDP inhibition of Gpp(NH)p activation has also been 
observed in mouse neuroblastoma cells (Levison and 
Blume, 1977). Although GDP clearly has an effect on 
Gpp(NH)p activation of locust adenylate cyclase, its 
mode of action remains speculative i.e. GDP may 
function as an inhibitor by "uncoupling" the guanine 
nucleotide protein and catalytic unit or simply pre­
vent the binding of Gpp(NH)p. However, the inhibi­
tory actions of GDP together with the failure of GDP 
to potentiate fully the activation of adenylate cy­
clase by the stimulatory ligand suggests that GDP may 
function by "uncoupling" the enzyme-guanine protein 
complex.
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Hormone-Guanyl Nucleotide Regulation of Adenylate Cyclase
Blume and Foster, 1976 suggested that the guanine nucleotide 
may be the primary enzyme regulator for neuroblastoma cells and 
that prostaglandin E^, the stimulatory ligand, may be consi­
dered to be a "secondary" cyclase regulator which acts on the 
primary regulatory mechanism. The observation that locust 
adenylate cyclase was activated substantially by Gpp(NH)p alone 
and that octopamine had a marginal stimulatory effect in the 
absence of guanyl nucleotides is consistent with this sugges­
tion. This idea will now be discussed in relation to current 
views on guanyl nucleotide interaction and hormone-mediated 
stimulation of adenylate cyclase. In particular, the results of 
this study will be compared with two models proposed to account 
for guanyl nucleotide hormone interaction in rat liver (Birn­
baumer et al, 19 80) and mouse neuroblastoma cells (Blume and 
Foster, 1976).
1. Rat Liver Adenylate Cyclase
Time course experiments showed that a lag could be ob­
served in the activation of rat liver adenylate cyclase, 
even in the presence of saturating concentrations of 
Gpp(NH)p (Salomon et al, 1975). This lag was abolished by 
the addition of glucagon. Thus, it was suggested that the 
hormone accelerates the slow guanyl nucleotide induced iso­
mérisation of an inactive to active form of the enzyme.
This together with the following observations led Birn­
baumer et al, 19 80 to propose a two state model for the 
regulation of adenylate cyclase (Figure 37).
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FIGURE 37
Adenylate Cyclase Regulation in Rat Liver 
(Birnbaumer et al, 1980} Iyengar et al, 1980)
E* GTP-ase
/
V
E'
where : E • = enzyme 
L = GTP 
D = GDP
Isomérisation rate
The model assumes that adenylate cyclase exists in two 
states, E° inactive and E ' active and that the equilibrium 
of the reaction is displaced towards E*^ . This is a result 
of the minimal activity observed in the absence of nucleo­
tides. In the presence of GTP or Gpp(NH)p, (L)E°^ is dis­
placed towards E t h u s  accounting for the activation by 
guanyl nucleotides. GTP but not Gpp(NH)p can be removed 
not only by dissociation but also through the action of 
the GTP-ase as suggested by Cassel and Selinger, 1976, 
1977. The formation of GDP (D) displaces the equilibrium 
of E^^ and E ' towards the inactive E°^ state. This is
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consistent with competitive inhibition by GDP of enzyme 
activation with Gpp(NH)p (Salomon et al, 19 75} Lin et al, 
1978). Evidence for an adenylate cyclase species, active 
in the absence of guanine nucleotides, was suggested by 
the finding that with turkey erythrocyte adenylate cyclase 
treated with GMP and isoproterenol, the initial rate of 
the GDP-free enzyme was high even in the absence of sub­
sequent hormone or guanyl nucleotides (Abramowitz et al,
19 80). Iyengar et al, 19 80 extended this model to account 
for hormone-receptor mediated stimulation of adenylate 
cyclase suggesting that the hormone functions by accele­
rating the isomérisation rate (K°^).
The addition of Gpp(NH)p (10 M^) stimulated locust adeny­
late cyclase without a lag being observed in time course 
experiments (Figure 31). Furthermore, this was not due to 
the method chosen for measuring cyclic AMP activity i.e. 
pre-incubation of the tissue with Gpp(NH)p for 5 minutes 
before initiating the reaction with ATP. If the assay was 
altered, such that the reaction was started by the addi­
tion of the tissue, a lag was not observed. Therefore, if 
a transition state exists, its interconversion must be 
very rapid.
2. Neuroblastoma Adenylate Cyclase
Blume and Foster, 19 76 proposed that for neuroblastoma 
cells, the enzyme GDP complex has to dissociate into the 
free enzyme plus GDP before GTP of Gpp(NH)p can interact
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with adenylate cyclase to form an active complex. Thus, 
unlike the previous model, the dissociation of GDP has 
been suggested to be the rate limiting step in the normal 
turnover cycle of the enzyme (Figure 38).
FIGURE 38
Regulation of Neuroblastoma Adenylate Cyclase 
(Blume and Foster, 19 76)
Eo
GTP
I -►EGTP >E GDP
Hormone
t
GDP
■>Eo
Inactive Active Inactive Inactive
A further difference between this model and the previous 
one is that the function of the hormone is to facilitate 
the removal of GDP from the guanine binding site. On the 
assumption that most of the "unstimulated” enzyme popu­
lation is in the state, shifting the equilibrium
Egdp towards E^ by adenylate cyclase activators would
make more of the enzyme available for binding of GTP and 
therefore increase the amount of active neuroblastoma 
adenylate cyclase.
Further evidence for the hormone being responsible for the 
removal of tightly bound GDP was implied by the obser-
3
vation that turkey erythrocyte membranes exposed to I H]-
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GTP and then washed, retained a small amount of radio­
activity identified as GDP. The rate of dissociation of
3
[ H]-GDP was stimulated by hormone suggesting that bound
3 3[ HJ-GDP was converted by the GTP-ase to [ H]-GDP and re­
tained until stimulated to exchange by hormone (Cassel and 
Selinger, 19 78) ,
As previously described, incubation of locust adenylate 
cyclase with Gpp(NH)p (10 M^) led to the formation of a 
stable enzyme which retained its activity even after ex­
tensive washing. The subsequent addition to the stable 
complex of either GTP or octopamine resulted in only a 
small reduction in adenylate cyclase activity. In con­
trast, in the presence of both GTP and octopamine, a sub­
stantial reduction in activity was observed implying that 
octopamine was necessary to induce the exchange of Gpp(NH)p 
by GTP before reversal of the stable complex could be 
achieved.
Pre-incubation of locust adenylate cyclase with GTP fol­
lowed by thorough washing resulted in the failure of the 
enzyme to be activated fully by the subsequent addition of 
Gpp(NH)p. Examination of the time course for the experi­
ment revealed that a lag occurred with the Gpp(NH)p acti­
vation. Furthermore, this lag was abolished by the addi­
tion of octopamine initially suggesting that a slow iso­
mérisation step similar to that observed with the rat 
liver enzyme occurs in the activation of locust adenylate 
cyclase by Gpp(NH)p. However, it seems more likely that
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the lag represents the time taken for Gpp(NH)p to remove 
the tightly bound nucleotide (presumably GDP) from the 
guanine nucleotide site. Support for this interpretation 
is based on the following:
a) The addition of Gpp(NH)p to an enzyme preparation 
pre-incubated in the absence of GTP i.e. with buffer, 
stimulated adenylate cyclase without a lag being 
observed in time course experiments.
“3b) Pre-incubation of locust adenylate cyclase with 10 M
- 4and 10 M GDP followed by washing to remove the free 
nucleotide resulted in a lag in Gpp(NH)p activation,
c) GDP (10 and 10 M^) inhibited Gpp(NH)p and Gpp(NH)p 
+ octopamine stimulated adenylate cyclase.
The observation that octopamine could abolish the lag 
suggests that whatever nucleotide was present at the 
guanine binding site, octopamine induces its exchange with 
Gpp(NH)p. Thus, the results presented are consistent with 
the model proposed by Blume and Foster, 1976 and suggest 
that locust adenylate cyclase is similar to the enzyme in 
mouse neuroblastoma cells.
The suggestion that GDP dissociation is the rate limiting 
step in the normal turnover cycle of adenylate cyclase has 
recently been questioned. If correct, it predicts that the 
rates of nucleotide activation of any adenylate cyclase should
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be independent of the nucleotide added. However, in aden­
ylate cyclase from rat liver (Birnbaumer et al, 19 80) and 
turkey erythrocyte cleared of endogenous GDP by isoprote­
renol plus GMP (Abramowitz et al, 1980), the rate of enzyme 
activation varied with each guanyl nucleotide. Thus, 
GTP(.Y)S > Gpp(NH)p > Gpp(CH2)p > GTP. In addition, the 
rate of activation of locust adenylate cyclase in the pre­
sence of Gpp(NH)p was greater than that observed with GTP. 
Therefore, this finding suggests that, although the re-; 
suits presented are consistent with the model proposed by 
Blume and Foster, 19 76, they do not provide conclusive 
proof for it.
Future Studies
Several questions are raised as a result of this study on ade­
nylate cyclase from locust cerebral ganglia;
I
1. The lag observed after pre-.incubation was interpreted as 
the result of the failure of Gpp(NH)p to replace GDP, 
formed by the hydrolysis of GTP by a GTP-ase. However, 
no evidence is presented in this study for the occurrence 
of a GTP-ase associated with locust adenylate cyclase.
Thus, repeating the work of Cassel and Selinger, 1977 and
3
1978, whereby the fate of [ H]-GTP is followed may provide 
evidence for a GTP-ase in the locust.
2. Although guanine nucleotides regulate adenylate cyclase 
activity, the molecular mechanism by which this occurs
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remains unclear. However, studies involving isolated 
guanine regulatory protein and adenylate cyclase from 
pigeon erythrocyte have indicated that activation requires 
the association of the two components (Pfeuffer, 19 79).
In contrast, evidence for a guanine binding protein- 
adenylate cyclase dissociation in the activation process 
has been suggested from x-ray inactivation studies on rat 
liver adenylate cyclase. Thus, from measuring the size of 
the complex before and after activation of adenylate cyclase 
Martin et al, 19 79 proposed the following model (Figure 40).
In the presence of Gpp(NH)p alone, the catalytic unit of 
adenylate cyclase (C) dissociates from the guanine regu­
latory component (G). The free catalytic unit is then 
fully activated. The dissociation of G from C is un­
affected by the independent glucagon receptor (R) which in 
the absence of hormone is not coupled to the catalytic 
unit or to the guanine binding component. Thus, the 
effect of Gpp(NH)p is essentially irreversible and com­
plete. In contrast, the effect of GTP is reversible in 
that an equilibrium is established between the activated, 
dissociated state (C) and the inactive associated state 
(CG). In the presence of glucagon, the receptor (R) 
associates with the CG complex to form a ternary complex 
(CGR) which dissociates to release a fully activated 
catalytic unit. Thus, the role of the hormone is to faci­
litate the action of GTP in causing the release of the 
free catalytic unit. This model, with only a slight modi­
fication, will also account for the results obtained in
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liver and neuroblastoma cells and, therefore, is consis­
tent with the rat liver and neuroblastoma models previously 
described. If the release of the free activated catalytic 
unit is time-dependent, then hormone acceleration of Step 
2 is consistent with the rat liver model. Equally, if GDP 
is not released by recombination of the catalytic unit and
the guanine binding protein Step 3, but is dependent on a
hormone-receptor interaction. Step 1, then this model is 
applicable to neuroblastoma cells.
Adenylate cyclase modelling is aimed at developing a 
single model which is applicable to all adenylate cyclases
(Birnbaumer et al, 1980} Iyengar et al, 1980). Further­
more, the model should not require a new assumption each 
time a new enzyme is found. At present, there is still 
debate as to whether the function of the hormone is to 
facilitate the release of inhibitory GDP from the nucleo­
tide binding site or to facilitate a slow isomérisation of 
an inactive to active form of the enzyme. Thus, it would 
appear that a single model must await the results of fur­
ther research.
3. Finally, although an octopamine-, dopamine- and serotonin- 
sensitive adenylate cyclase exists in locust cerebral 
ganglia, not all the physiological responses to these 
enzymes necessarily involve an alteration of adenylate 
cyclase activity. A dopamine-sensitive adenylate cyclase 
has been identified in mammalian substantia nigra (Keba­
bian and Saavedra, 19 76) and striatum (Kebabian et al,
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19 72). However, the enzyme would appear to occur outwith 
"dopaminergic" neurons. Lesions in the nigra and striatum 
induced by 6-hydroxydopamine (which selectively destroys 
dopaminergic neurons) do not alter the activity of dopa­
mine-sensitive adenylate cyclase within either the nigra 
(Kebabian and Saavedra, 1976) or striatum (Krueger et al, 
1976), Furthermore, injection of 6-hydroxydopamine into 
rat substantia nigra (Quik et al, 1979) depleted the 
binding of the dopaminergic antagonist spiroperidol but 
failed to reduce the dopamine-sensitive adenylate cyclase. 
Thus, an indication of whether the dopamine-sensitive 
adenylate cyclase in locust is associated with dopamin­
ergic neurons is possible from studies using 6-hydroxy­
dopamine .
The identification of the factors involved in the acti­
vation of locust adenylate cyclase was a prerequisite 
before commencement of studies on cyclic AMP induced 
phosphorylation of membrane proteins could begin. Thus, 
the finding that locust adenylate cyclase was stimulated 
by octopamine, dopamine and serotonin will lead to 
studies designed to determine whether these monoamines 
also induce phosphorylation of membrane proteins. Fur­
thermore, the observation that the octoparaine-sensitive 
adenylate cyclase (Table 6) was enriched in a fraction 
(F2) previously shown to contain a high proportion of 
cholinergic nerve endings (Donnellan et al, 1976)and 
presumably other types of nerve endings will allow the 
phosphorylation of a possible nerve ending fraction to be 
studied.
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FIGURE 40
Activation of Adenylate Cyclase by 
Glucagon and Guanine Nucleotides 
(Martin et al, 1979)
Gpp(NH)p
i
(a)
GTP
GDP+Pi
Glucagon
(1 ) i
Glucagon
(b)
-GTP
(Gpp(NH)p)
GDP+Pi Glucagon
Glucagon
t
GTP
The figure describes the model proposed for alteration in the aggre­
gation state of adenylate cyclase during activation by guanine nucleo­
tides (1) or by guanine nucleotides in the presence of glucagon (b). 
The glucagon receptor is represented by R, the catalytic unit by C and 
the GTP binding unit by G.
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At present, however, little is known about the functional 
role of cyclic AMP in monoaminergic neurotransmission in 
insects and it would appear that a definitive demonstration 
of a cyclic AMP involvement must await the results of 
further studies on identified aminergic neurons.
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